Conference Agenda

Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).

 
 
Session Overview
Date: Wednesday, 27/Aug/2025
9:00am
-
10:30am
Cracking causal questions: Estimands for reliable and clinically relevant evidence
Location: Biozentrum U1.111
 

Chasing Shadows: How Implausible Assumptions Skew Our Understanding of Causal Estimands

Kelly Van Lancker, Stijn Vansteelandt



Paving the ground for breakthrough innovations in Alzheimer’s Disease drug development with the estimand framework and causal inference

Paul DELMAR, Marion Monchalin, Rachid Abbas



Estimating causal overall survival estimands in the presence of treatment switching using multi-state models

Alexandra Bühler, Tobias Mütze, Lisa Hampson, Jiali Wang, Tomas Haas

Design and evaluation of clinical trials
Location: Biozentrum U1.131
 

Clinical trial simulation: Planning, implementation and validation principles

Kim May Lee, Babak Choodari-Oskooei, Michael J. Grayling, Peter Jacko, Peter K. Kimani, Aritra Mukherjee, Philip Pallmann, Tom Parke, David S. Robertson, Ziyan Wang, Christina Yap, Thomas Jaki



Early Phase Dose-Finding Designs for CAR-T cell Therapies

Weishi Chen, Pavel Mozgunov, Xavier Paoletti



Fast approximation of the operating characteristics in clinical trials

Susanna Gentile, Daniel Schwartz, Riddhiman Saha, Lorenzo Trippa



Quantifying the effects of screening – a re-randomisation approach

Vichithranie Wasantha Madurasinghe, Bethany Shinkins, Keith R Abrams, Sian Taylor-phillips



From Methodology to Mindset: Implementing Quantitative Decision-Making Framework into Early Development Clinical Trials

Stefan Englert, Leen Slaets, Lilla Di Scala

Competing events and multi-state modelling
Location: Biozentrum U1.141
 

A general approach to fitting multistate cure models based on an extended-long-format data structure

Yilin Jiang, Harm van Tinteren, Marta Fiocco



Calibration of cause-specific absolute risk for external validation using each cause-specific hazards model in the presence of competing events

Sarwar Islam Mozumder, Sarah Booth, Richard Riley, Mark Rutherford, Paul Lambert



Multi-state models with restricted transition windows: The impact of time scale choice

Georgy Gomon, Ilaria Prosepe, Rachel Knevel, Saskia le Cessie



Integrating Landmarking and Competing Risks in Survival Analysis with Machine Learning Techniques

Shirin Sultana, Dr. Md Hasinur Rahaman Khan



Survival without vs after transition to the intermediate event in a non-markovian “illness-death” model: application to heart transplant data

Davide Paolo Bernasconi, Lorenzo Del Castello, Laura Antolini

Machine learning 2
Location: Biozentrum U1.101
 

Asymmetric Shapley values to quantify the importance of genomic variables in clinical prediction studies

Mark van de Wiel



Fused Estimation of Varying Omics Effects for Clinico-genomic Data

Jeroen Goedhart, Mark van de Wiel, Wessel van Wieringen, Thomas Klausch



Random forests using longitudinal predictors

Justine Remiat, Cécile Proust-Lima, Robin Genuer



Digital Twins you can ‘count’ on: a novel application of digital-twin prognostic scores in Negative-Binomial models.

Tasos Papanikos, Doug Thompson, Harry Parr, Aris Perperoglou



Calibrating machine learning approaches for probability estimation in case of the absence of calibration data

Eleonora Di Carluccio, Giorgos Koliopanos, Francisco Ojeda, Christian Weimar, Andreas Ziegler

Prediction / prognostic modelling 3
Location: ETH E27
 

Predicting Prediction Performance

Max Westphal, Rieke Alpers



Predictive modelling with block missingness

Viktor Racinskij, Robin Mitra, Chris Harbron, Niels Hagenbuch



Lifestyle Predictors of All-Cause Mortality: Enhancing Risk Models Beyond Traditional Biomarkers

Yuhe Wang, Cameron Razieh, Thomas Yates



Development and validation of the Options model, a clinical prediction model predicting risk of emergency caesarean births in nulliparous women

Alexandra Hunt



Optimizing Dynamic Predictions from Joint Models using Super Learning

Dimitris Rizopoulos, Jeremy M.G. Taylor

Infectious disease and longitudinal modelling
Location: ETH E23
 

Estimating transmission parameters of stochastic epidemic models using survival analysis techniques

Hein Putter, Chengyuan Lu, Jacco Wallinga



Estimating Mean Viral Load Trajectory at the Beginning of a pandemic

Yonatan Woodbridge, Micha Mandel, Yair Goldberg, Amit Huppert



Investigating the Association between Risky Sexual Behaviors and HIV Risk Using Multivariate Joint Models

Nobuhle Nokubonga Mchunu, Henry Mwambi, Tarylee Reddy, Nonhlanhla Yende-Zuma, Dimitris Rizopoulos



Revealing Platelet Aggregation Dynamics: A Functional Data Analysis Approach Using Penalized Splines and Linear Mixed Models.

Souvik Kumar Bandyopadhyay



Source Data Mapping Approach to CDMV5.4: Innovations in Longitudinal Data Integration for Machine Learning Application

Bylhah Mugotitsa, Michael Ochola, Pauline Andeso, David Amadi, Reinpeter Momanyi, Evans Omondi, Jim Todd, Agnes Kiragga

Biomarker studies & mixed topics
Location: ETH E21
 

Quantifying the Clinical Usefulness of Novel Biomarkers and Tests: Beyond Traditional Statistics

Frank Doornkamp, Jelle J Goeman, Ewout W Steyerberg



The underlap coefficient as measure of a biomarker’s discriminatory ability in a multi-class disease setting

Zhaoxi Zhang, Vanda Inácio, Miguel de Carvalho



Time-dependent accuracy for Continuous Biomarkers using Copula Modelling

Adina Najwa Kamarudin, Ahmad Faiz Mohd Azhar, Nurain Ibrahim



Sample size determination for hypothesis testing of the intraclass correlation coefficient for agreement in two-way ANOVA models

Dipro Mondal, Alberto Cassese, Math JJM Candel, Sophie Vanbelle



Accounting for misclassification of binary outcomes in external control arm studies for unanchored indirect comparisons: simulations and applied example

Mikail Nourredine, Antoine Gavoille, Côme Lepage, Behrouz Kassai-Koupai, Michel Cucherat, Fabien Subtil

Poster Exhibition: W / Wednesday posters
Location: Poster Location
 

Exploring the Exposome correlated with Body Mass Index in Adolescents: Findings from the 2014-2015 and 2022-2023 KNHANES

Hye Ah Lee, Hyesook Park



Flexible statistical modeling of undernutrition among under-five children in India

SHAMBHAVI MISHRA



Comparison of deep learning models with different architectures and training populations for ECG age estimation: Accuracy, agreement, and CVD prediction

Arya Panthalanickal Vijayakumar, Tom Wilsgaard, Henrik Schirmer, Ernest Diez Benavente, René van Es, Rutger R. van de Leur, Haakon Lindekleiv, Zachi I. Attia, Francisco Lopez-Jimenez, David A. Leon, Olena Iakunchykova



Systematic review and real life-oriented evaluation on methods for feature selection in longitudinal biomedical data

Alexander Gieswinkel, Gregor Buch, Gökhan Gül, Vincent ten Cate, Lisa Hartung, Philipp S. Wild



How does acute exposure to environmental factors relate to stroke characteristics such as stroke type, severity, and impairments?

BOHAN ZHANG, Andy Vail, Craig Smith, Amit Kishore, Matthew Gittins



Improving TBI Prognosis in developing world: A Machine Learning-based AutoScore Approach to Predict Six-Month Functional Outcome

Vineet Kumar Kamal, Deepak Agrawal



Predictive Risk Index for Poor Cognitive Development Among Children Using Machine Learning Approaches

Anita Kerubo Ogero, Patricia Kipkemoi, Amina Abubakar



Development and validation of a model to predict ceiling of care in COVID-19 hospitalised patients

Natàlia Pallarès Fontanet, Hristo Inouzhe, Jordi Cortés, Sam Straw, Klaus K Witte, Jordi Carratalà, Sebastià Videla, Cristian Tebé



Transformer Models for Clinical Prediction – Investigation of BEHRT in UK Biobank and prediction assessment under different scenarios

Yusuf Yildiz, Goran Nenadic, Meghna Jani, David A. Jenkins



What is the best way to analyse ventilator-free days?

Laurent Renard Triché, Matthieu Jabaudon, Bruno Pereira, Sylvie Chevret



Compare Estimation and Classification Performances of Statistical Shrinkage Methods Ridge Regression, Lasso Regression, and Elastic Net Regression

Gamze Ozen, Fezan Mutlu



Defining Harm in Settings with Outcomes that are Not Binary

Amit Sawant, Mats Stensrud



Brier pseudo-observation score for selecting a multiplicative, an additive or an additive-multiplicative hazards regression model

François Lefebvre, Roch Giorgi



Bayesian spatio-temporal analysis of the COVID-19 pandemic in Catalonia

Pau Satorra, Cristian Tebé



A Simulation Study of Bayesian Approaches to Spatial Modelling Using the Besag-York-Mollie Model

Hollie Hughes, David Hughes



A Bayesian analysis of FINEARTS-HF

Alasdair D Henderson, Brian L Claggett, Akshay S Desai, Mutthiah Vaduganathan, Carolyn S Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Meike Brinker, Flaviana Amarante, Katja Rohwedder, James Lay-Flurrie, Scott D Solomon, John JV McMurray, Pardeep S Jhund



Fast Approximation of Joint Models: A Comparative Evaluation of Bayesian Methods

Jinghao Li, David M Hughes



Confidence Intervals for Comparing Two Independent Folded Normals

Eleonora Di Carluccio, Sarah Ogutu, Ozkan Köse, Henry G. Mwambi, Andreas Ziegler



Towards Realistic Synthetic Nanopore Protein Signals: A Comparative Study of Stochastic and GAN-Based Methods

Göran Köber, Jonas Bürgel, Tobias Ensslen, Oliver Amft



Data Transformations in Machine Learning Approaches for Studying Microbiota as a Biomarker of Non-Response Risk to CFTR Modulators

Marta Avalos, Céline Hosteins, Diego Kauer, Chloé Renault, Raphaël Enaud, Laurence Delhaes



On microbiome data analysis using Bayesian method under the assumption of a zero-inflated model

Yuki Ando, Asanao Shimokawa



Estimating prevalence of cystic fibrosis heterozygosity using Fast Boltzmann Inversion (FBI): An improved Monte Carlo algorithm for Bayesian inference

Jan Brink Valentin



A Sparse Graph Representation of Hi-C Data for Colorectal Cancer Prediction

Jiwon Im, Mingyu Go, Insu Jang, Minsu Park



A multi-state survival model for recurring adenomas in Lynch syndrome individuals

Vanessa García López-Mingo, Veerle Coupé, Marjolein Greuter, Thomas Klausch



Evaluating Completeness of Data in CPRD’s Breast Cancer Data: Implications for External Controls for Surrogate Endpoints

Dorcas N Kareithi, Jingky Lozano-Kuehne, David Sinclair, James Wason



Identification of risk factors for the development of de novo malignancies after liver transplantation

Tereza Hakova, Pavel Taimr, Tomáš Hucl, Zdeněk Valenta



Are ACE inhibitors associated with increased lung cancer risk, or are unmeasured confounders biasing results?

Sean Maguire, Ruth Keogh, Elizabeth Williamson, John Tazare



DO GENETIC CHANGES IN 15Q13.3 MEAN LOWER IQ SCORE?

Tadas Žvirblis, Pilar Caro, Audronė Jakaitienė, Christian Schaaf



Measuring the performance of survival models to personalize treatment choices

Orestis Efthimiou, Jeroen Hoogland, Thomas Debray, Valerie Aponte Ribero, Wilma Knol, Huiberdina Koek, Matthias Schwenkglenks, Séverine Henrard, Matthias Egger, Nicolas Rodondi, Ian White



A framework for estimating quality adjusted life years using joint models of longitudinal and survival data

Michael Crowther, Alessandro Gasparini, Sara Ekberg, Federico Felizzi, Elaine Gallagher, Noman Paracha



Cut Off Determination using Model Derived Estimate in Survival Prediction Model

Jungbok Lee



A two-step testing approach for comparing time-to-event data under non-proportional hazards

Jonas Brugger, Tim Friede, Florian Klinglmüller, Martin Posch, Franz König



A systematic review of Bayesian survival modelling for extrapolating survival in cost-effectiveness analysis

Farah Erdogan, Gwénaël Le Teuff



Power comparison of hazard ratio versus restricted mean survival time in the presence of cure

Ronald Bertus Geskus



Sample Size Calculation in Prognostic Studies: A Comparative Analysis

Gloria Brigiari, Ester Rosa, Giulia Lorenzoni, Dario Gregori



Prognostic Score Adjustment in a Two-Slope Mixed Effects Model to Estimate Treatment Effects on eGFR Slope in CKD Patients

Silke Janitza, Maike Ahrens, Sebastian Voss, Bohdana Ratitch, Nicole Rethemeier, Meike Brinker, Paula Vesterinen, Antigoni Elefsinioti



Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers to prevent or delay dementia: a target trial emulation

Marie-Laure Charpignon, Max Sunog, Colin Magdamo, Bella Vakulenko-Lagun, Ioanna Tzoulaki, Sudeshna Das, Deborah Blacker, Mark Albers



Optimal utility-based design of phase II/phase III programmes with different type of endpoints in the setting of multiple myeloma

Haotian Wang, Peter Kimani, Michael Grayling, Josephine Khan, Nigel Stallard



Beyond first events: Advancing recurrent adverse event estimates in clinical research.

Nicolas Sauvageot, Leen Slaets, Anirban Mitra, Zoe Craig, Jane Gilbert, Lilla Di Scala, Stefan Englert



Cure models to compare aftercare monitoring schemes in pediatric cancer

Ulrike Pötschger, Harm van Tinteren, Evgenia Glogova, Helga Arnardottir, Paulina Kurzmann, Sabine Taschner-Mandl, Lieve Titgat, Martina Mittlböck



Comparison of treatment sequences in advanced pancreatic cancer

Norbert Marschner, Nina Haug, Susanna Hegewisch-Becker, Marcel Reiser, Steffen Dörfel, Rüdiger Liersch, Hartmut Linde, Thomas Wolf, Anna Hof, Anja Kaiser-Osterhues, Karin Potthoff, Martina Jänicke



Clinical Trials with Time-to-event-endpoint: Interim Prediction of Number of Events with Confidence Distributions

Edoardo Ratti, Maria Grazia Valsecchi, Stefania Galimberti



A Bayesian-Informed Dose-Escalation Design for Multi-Cohort Oncology Trials with Varying Maximum Tolerated Doses

Martin Kappler, Yuan Ji



Comparison of Bayesian Approaches in Single-Agent Dose-Finding Studies

Vibha Srichand



Evaluating the effect of different non-informative prior specifications on the Bayesian proportional odds model in randomised controlled trials

Chris J Selman, Katherine J Lee, Michael Dymock, Ian Marschner, Steven Y.C. Tong, Mark Jones, Tom Snelling, Robert K Mahar



Bayesian decision analysis for clinical trial design with binary outcome in the context of Ebola Virus Disease outbreak – Simulation study

Drifa Belhadi, Joonhyuk Cho, Pauline Manchon, Denis Malvy, France Mentré, Andrew W Lo, Cédric Laouénan



Relevance of Electronic Medical Records for Clinical Trial Eligibility: A Feasibility Assessment in Acute Stroke Studies

Yusuke Sasahara, Taizo Murata, Yasufumi Gon, Toshihiro Takeda, Eisuke Hida



Navigating complex and computationally demanding clinical trial simulation

Saumil Shah, Mitchell Thomann



Transforming Clinical Trials: The Power of Synthetic Data in Augmenting Control Arms

Emmanuelle Boutmy, Shane O Meachair, Julie Zhang, Sabrina de Souza, Saheli Das, Dina Oksen, Anna Tafuri, Lucy Mosquera



Integrating stakeholder perspectives in modeling routine data for therapeutic decision-making

Michelle Pfaffenlehner, Andrea Dreßing, Dietrich Knoerzer, Markus Wagner, Peter Heuschmann, André Scherag, Harald Binder, Nadine Binder



Aligning Synthetic Trajectories from Expert-Based Models with Real Patient Data Using Low-Dimensional Representations

Hanning Yang, Meropi Karakioulaki, Cristina Has, Moritz Hess, Harald Binder



Integrating semantic information in care pathway studies with medical code embeddings, application to the case of Amyotrophic Lateral Sclerosis

Corentin FAUJOUR, Stéphane BOUEE, Corinne EMERY, Anne-Sophie JANNOT



Inequalities in impact of respiratory viruses: development and analysis of respiratory virus phenotypes in EHRs from England using OpenSAFELY

Em Prestige, Jennifer K. Quint, Charlotte Warren-Gash, William Hulme, Edward PK Parker, Elizabeth Williamson, Rosalind M. Eggo



Modeling Longitudinal Clinical Outcomes: Comparison of Generalized Linear Models, Generalized Estimating Equations, and Marginalized Multilevel Models in Pediatric Intensive Care

Luca Vedovelli, Stefania Lando, Danila Azzolina, Corrado Lanera, Ileana Baldi, Dario Gregori



Modelling the costeffectiveness of Truvada for the Prevention of Mother to Child Prevention (PMTCT) of Hepatitis B Virus in Botswana

Graceful Mulenga, Motswedi Anderson, Simani Gaseitsiwe



Application of machine learning methods for the analysis of randomised controlled trials: A systematic review

Xiao Xuan Tan, Rachel Phillips, Mansour Taghavi Azar Sharabiani



Joint longitudinal modelling of non-normally distributed outcomes and endogenous covariates

Chiara Degan, Bart Mertens, Pietro Spitali, Erik H. Niks, Jelle Goeman, Roula Tsonaka



Mediation analysis for exploring gender differences in mortality among acute myocardial infarction

Alice Bonomi, Arianna Galotta, Francesco Maria Mattio, Lorenzo Cangiano, Giancarlo Marenzi



Bivariate random-effects models for the meta-analysis of rare events

Danyu Li, Patrick Taffe



Time-varying Decomposition of Direct and Indirect Effects with Multiple Longitudinal Mediators

Yasuyuki Okuda, Masataka Taguri



Causal framework for analyzing mediation effects of clinical biomarkers

Jinesh Shah



A Modified Doubly Robust Estimator for Clustered Causal Inference: Integrating GLMM and GBM

Samina Naznin, Dr. Mohaimen Monsur



DoubleMLDeep: Estimation of Causal Effects with Multimodal Data

Martin Spindler, Victor Chernozhukov, Philipp Bach, Jan Teichert-Kluge, Sven Klaassen, Suhas Vijaykumar



Causal Machine Learning Methods for Estimating Personalised Treatment Effects - Insights on validity from two large trials

Hongruyu Chen, Helena Aebersold, Milo Alan Puhan, Miquel Serra-Burriel



Challenges with subgroup analyses in individual participant data meta-analysis of randomised trials

Alain Amstutz, Dominique Costagliola, Corina S. Rueegg, Erica Ponzi, Johannes M. Schwenke, France Mentré, Clément R. Massonnaud, Cédric Laouénan, Aliou Baldé, Lambert Assoumou, Inge C. Olsen, Matthias Briel, Stefan Schandelmaier



Illustration and evaluation of a causal approach to sensitivity analysis for unmeasured confounding using measured proxies with a simulation study

Nerissa Nance, Romain Neugebauer



Quantifying causal treatment effect on binary outcome in RCTs with noncompliance: estimating risk difference, risk ratio and odds ratio

Junxian Zhu, Mark Y. Chan, Bee-Choo Tai



Blinded sample size recalculation for randomized controlled trials with analysis of covariance

Takumi Kanata, Yasuhiro Hagiwara, Koji Oba



Variance stabilization transformation for the intraclass correlation coefficient of agreement with an application example to meta-analyses of inter-rater reliability studies

Abderrahmane Bourredjem, Isabelle Fournel, Sophie Vanbelle, Nadjia El Saadi



Bridging Single Arm Studies with Individual Participant Data in Network Meta-Analysis of Randomized Controlled Trials: A Simulation Study

Katerina Maria Kontouli, Stavros Nikolakopoulos, Christos Christogiannis, Dimitrios Mavridis



Comparative Efficacy and Safety of Migraine Treatments: A Network Meta-Analysis of Clinical Outcomes

Shashank Tripathi, Rachna Agarwal



Optimal standardization as an alternative to matching using propensity scores

Ekkehard Glimm, Lillian Yau



Evaluating Diagnostic Tests Against Composite Reference Standards: Quantifying and Adjusting for Bias

Vera Hudak, Nicky J. Welton, Efthymia Derezea, Hayley Jones



Characteristics, Design and Statistical Methods in Platform Trials: A Systematic Review

Clément R. Massonnaud, Christof Manuel Schönenberger, Malena Chiaborelli, Selina Ehrenzeller, Alexandra Griessbach, André Gillibert, Matthias Briel, Cédric Laouénan



WRestimates: An R Package for Win-Ratio Sample Size and Power Calculations

Autumn O Donnell



Randomizing With Investigator Choice of Treatment: A Powerful Pragmatic Tool in Clinical Trials

Lillian Yau, Betty Molloy



Confirming assay sensitivity in 2-arm non-inferiority trial using meta-analytic-predictive approach

Satomi OKAMURA, Eisuke HIDA



Adding baskets to an ongoing basket trial with information borrowing: When do you benefit?

Libby Daniells, Pavel Mozgunov, Helen Barnett, Alun Bedding, Thomas Jaki



Optimizing Adaptive Trial Design to Ensure Robustness Across Varying Treatment Effect Assumptions

Valeria Mazzanti, Dirk Klingbiel



N-of-1 Trials to Estimate Individual Effects of Music on Concentration

Thomas Gärtner, Fabian Stolp, Stefan Konigorski



Simulation Study Examining Impact of Study Design Factors on Variability Measures

Laura Quinn, Jon Deeks, Yemisi Takwoingi, Alice Sitch



Simulation-based optimization of adaptive designs using a generalized version of assurance

Pantelis Vlachos, Valeria Mazzanti, Boaz Adler



Evaluating the impact of outcome delay on adaptive designs

Aritra Mukherjee, Michael J. Grayling, James M. S. Wason

10:30am
-
11:00am
Coffee Break
Poster Exhibition: W / Wednesday posters
Location: Poster Location
 

Exploring the Exposome correlated with Body Mass Index in Adolescents: Findings from the 2014-2015 and 2022-2023 KNHANES

Hye Ah Lee, Hyesook Park



Flexible statistical modeling of undernutrition among under-five children in India

SHAMBHAVI MISHRA



Comparison of deep learning models with different architectures and training populations for ECG age estimation: Accuracy, agreement, and CVD prediction

Arya Panthalanickal Vijayakumar, Tom Wilsgaard, Henrik Schirmer, Ernest Diez Benavente, René van Es, Rutger R. van de Leur, Haakon Lindekleiv, Zachi I. Attia, Francisco Lopez-Jimenez, David A. Leon, Olena Iakunchykova



Systematic review and real life-oriented evaluation on methods for feature selection in longitudinal biomedical data

Alexander Gieswinkel, Gregor Buch, Gökhan Gül, Vincent ten Cate, Lisa Hartung, Philipp S. Wild



How does acute exposure to environmental factors relate to stroke characteristics such as stroke type, severity, and impairments?

BOHAN ZHANG, Andy Vail, Craig Smith, Amit Kishore, Matthew Gittins



Improving TBI Prognosis in developing world: A Machine Learning-based AutoScore Approach to Predict Six-Month Functional Outcome

Vineet Kumar Kamal, Deepak Agrawal



Predictive Risk Index for Poor Cognitive Development Among Children Using Machine Learning Approaches

Anita Kerubo Ogero, Patricia Kipkemoi, Amina Abubakar



Development and validation of a model to predict ceiling of care in COVID-19 hospitalised patients

Natàlia Pallarès Fontanet, Hristo Inouzhe, Jordi Cortés, Sam Straw, Klaus K Witte, Jordi Carratalà, Sebastià Videla, Cristian Tebé



Transformer Models for Clinical Prediction – Investigation of BEHRT in UK Biobank and prediction assessment under different scenarios

Yusuf Yildiz, Goran Nenadic, Meghna Jani, David A. Jenkins



What is the best way to analyse ventilator-free days?

Laurent Renard Triché, Matthieu Jabaudon, Bruno Pereira, Sylvie Chevret



Compare Estimation and Classification Performances of Statistical Shrinkage Methods Ridge Regression, Lasso Regression, and Elastic Net Regression

Gamze Ozen, Fezan Mutlu



Defining Harm in Settings with Outcomes that are Not Binary

Amit Sawant, Mats Stensrud



Brier pseudo-observation score for selecting a multiplicative, an additive or an additive-multiplicative hazards regression model

François Lefebvre, Roch Giorgi



Bayesian spatio-temporal analysis of the COVID-19 pandemic in Catalonia

Pau Satorra, Cristian Tebé



A Simulation Study of Bayesian Approaches to Spatial Modelling Using the Besag-York-Mollie Model

Hollie Hughes, David Hughes



A Bayesian analysis of FINEARTS-HF

Alasdair D Henderson, Brian L Claggett, Akshay S Desai, Mutthiah Vaduganathan, Carolyn S Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Meike Brinker, Flaviana Amarante, Katja Rohwedder, James Lay-Flurrie, Scott D Solomon, John JV McMurray, Pardeep S Jhund



Fast Approximation of Joint Models: A Comparative Evaluation of Bayesian Methods

Jinghao Li, David M Hughes



Confidence Intervals for Comparing Two Independent Folded Normals

Eleonora Di Carluccio, Sarah Ogutu, Ozkan Köse, Henry G. Mwambi, Andreas Ziegler



Towards Realistic Synthetic Nanopore Protein Signals: A Comparative Study of Stochastic and GAN-Based Methods

Göran Köber, Jonas Bürgel, Tobias Ensslen, Oliver Amft



Data Transformations in Machine Learning Approaches for Studying Microbiota as a Biomarker of Non-Response Risk to CFTR Modulators

Marta Avalos, Céline Hosteins, Diego Kauer, Chloé Renault, Raphaël Enaud, Laurence Delhaes



On microbiome data analysis using Bayesian method under the assumption of a zero-inflated model

Yuki Ando, Asanao Shimokawa



Estimating prevalence of cystic fibrosis heterozygosity using Fast Boltzmann Inversion (FBI): An improved Monte Carlo algorithm for Bayesian inference

Jan Brink Valentin



A Sparse Graph Representation of Hi-C Data for Colorectal Cancer Prediction

Jiwon Im, Mingyu Go, Insu Jang, Minsu Park



A multi-state survival model for recurring adenomas in Lynch syndrome individuals

Vanessa García López-Mingo, Veerle Coupé, Marjolein Greuter, Thomas Klausch



Evaluating Completeness of Data in CPRD’s Breast Cancer Data: Implications for External Controls for Surrogate Endpoints

Dorcas N Kareithi, Jingky Lozano-Kuehne, David Sinclair, James Wason



Identification of risk factors for the development of de novo malignancies after liver transplantation

Tereza Hakova, Pavel Taimr, Tomáš Hucl, Zdeněk Valenta



Are ACE inhibitors associated with increased lung cancer risk, or are unmeasured confounders biasing results?

Sean Maguire, Ruth Keogh, Elizabeth Williamson, John Tazare



DO GENETIC CHANGES IN 15Q13.3 MEAN LOWER IQ SCORE?

Tadas Žvirblis, Pilar Caro, Audronė Jakaitienė, Christian Schaaf



Measuring the performance of survival models to personalize treatment choices

Orestis Efthimiou, Jeroen Hoogland, Thomas Debray, Valerie Aponte Ribero, Wilma Knol, Huiberdina Koek, Matthias Schwenkglenks, Séverine Henrard, Matthias Egger, Nicolas Rodondi, Ian White



A framework for estimating quality adjusted life years using joint models of longitudinal and survival data

Michael Crowther, Alessandro Gasparini, Sara Ekberg, Federico Felizzi, Elaine Gallagher, Noman Paracha



Cut Off Determination using Model Derived Estimate in Survival Prediction Model

Jungbok Lee



A two-step testing approach for comparing time-to-event data under non-proportional hazards

Jonas Brugger, Tim Friede, Florian Klinglmüller, Martin Posch, Franz König



A systematic review of Bayesian survival modelling for extrapolating survival in cost-effectiveness analysis

Farah Erdogan, Gwénaël Le Teuff



Power comparison of hazard ratio versus restricted mean survival time in the presence of cure

Ronald Bertus Geskus



Sample Size Calculation in Prognostic Studies: A Comparative Analysis

Gloria Brigiari, Ester Rosa, Giulia Lorenzoni, Dario Gregori



Prognostic Score Adjustment in a Two-Slope Mixed Effects Model to Estimate Treatment Effects on eGFR Slope in CKD Patients

Silke Janitza, Maike Ahrens, Sebastian Voss, Bohdana Ratitch, Nicole Rethemeier, Meike Brinker, Paula Vesterinen, Antigoni Elefsinioti



Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers to prevent or delay dementia: a target trial emulation

Marie-Laure Charpignon, Max Sunog, Colin Magdamo, Bella Vakulenko-Lagun, Ioanna Tzoulaki, Sudeshna Das, Deborah Blacker, Mark Albers



Optimal utility-based design of phase II/phase III programmes with different type of endpoints in the setting of multiple myeloma

Haotian Wang, Peter Kimani, Michael Grayling, Josephine Khan, Nigel Stallard



Beyond first events: Advancing recurrent adverse event estimates in clinical research.

Nicolas Sauvageot, Leen Slaets, Anirban Mitra, Zoe Craig, Jane Gilbert, Lilla Di Scala, Stefan Englert



Cure models to compare aftercare monitoring schemes in pediatric cancer

Ulrike Pötschger, Harm van Tinteren, Evgenia Glogova, Helga Arnardottir, Paulina Kurzmann, Sabine Taschner-Mandl, Lieve Titgat, Martina Mittlböck



Comparison of treatment sequences in advanced pancreatic cancer

Norbert Marschner, Nina Haug, Susanna Hegewisch-Becker, Marcel Reiser, Steffen Dörfel, Rüdiger Liersch, Hartmut Linde, Thomas Wolf, Anna Hof, Anja Kaiser-Osterhues, Karin Potthoff, Martina Jänicke



Clinical Trials with Time-to-event-endpoint: Interim Prediction of Number of Events with Confidence Distributions

Edoardo Ratti, Maria Grazia Valsecchi, Stefania Galimberti



A Bayesian-Informed Dose-Escalation Design for Multi-Cohort Oncology Trials with Varying Maximum Tolerated Doses

Martin Kappler, Yuan Ji



Comparison of Bayesian Approaches in Single-Agent Dose-Finding Studies

Vibha Srichand



Evaluating the effect of different non-informative prior specifications on the Bayesian proportional odds model in randomised controlled trials

Chris J Selman, Katherine J Lee, Michael Dymock, Ian Marschner, Steven Y.C. Tong, Mark Jones, Tom Snelling, Robert K Mahar



Bayesian decision analysis for clinical trial design with binary outcome in the context of Ebola Virus Disease outbreak – Simulation study

Drifa Belhadi, Joonhyuk Cho, Pauline Manchon, Denis Malvy, France Mentré, Andrew W Lo, Cédric Laouénan



Relevance of Electronic Medical Records for Clinical Trial Eligibility: A Feasibility Assessment in Acute Stroke Studies

Yusuke Sasahara, Taizo Murata, Yasufumi Gon, Toshihiro Takeda, Eisuke Hida



Navigating complex and computationally demanding clinical trial simulation

Saumil Shah, Mitchell Thomann



Transforming Clinical Trials: The Power of Synthetic Data in Augmenting Control Arms

Emmanuelle Boutmy, Shane O Meachair, Julie Zhang, Sabrina de Souza, Saheli Das, Dina Oksen, Anna Tafuri, Lucy Mosquera



Integrating stakeholder perspectives in modeling routine data for therapeutic decision-making

Michelle Pfaffenlehner, Andrea Dreßing, Dietrich Knoerzer, Markus Wagner, Peter Heuschmann, André Scherag, Harald Binder, Nadine Binder



Aligning Synthetic Trajectories from Expert-Based Models with Real Patient Data Using Low-Dimensional Representations

Hanning Yang, Meropi Karakioulaki, Cristina Has, Moritz Hess, Harald Binder



Integrating semantic information in care pathway studies with medical code embeddings, application to the case of Amyotrophic Lateral Sclerosis

Corentin FAUJOUR, Stéphane BOUEE, Corinne EMERY, Anne-Sophie JANNOT



Inequalities in impact of respiratory viruses: development and analysis of respiratory virus phenotypes in EHRs from England using OpenSAFELY

Em Prestige, Jennifer K. Quint, Charlotte Warren-Gash, William Hulme, Edward PK Parker, Elizabeth Williamson, Rosalind M. Eggo



Modeling Longitudinal Clinical Outcomes: Comparison of Generalized Linear Models, Generalized Estimating Equations, and Marginalized Multilevel Models in Pediatric Intensive Care

Luca Vedovelli, Stefania Lando, Danila Azzolina, Corrado Lanera, Ileana Baldi, Dario Gregori



Modelling the costeffectiveness of Truvada for the Prevention of Mother to Child Prevention (PMTCT) of Hepatitis B Virus in Botswana

Graceful Mulenga, Motswedi Anderson, Simani Gaseitsiwe



Application of machine learning methods for the analysis of randomised controlled trials: A systematic review

Xiao Xuan Tan, Rachel Phillips, Mansour Taghavi Azar Sharabiani



Joint longitudinal modelling of non-normally distributed outcomes and endogenous covariates

Chiara Degan, Bart Mertens, Pietro Spitali, Erik H. Niks, Jelle Goeman, Roula Tsonaka



Mediation analysis for exploring gender differences in mortality among acute myocardial infarction

Alice Bonomi, Arianna Galotta, Francesco Maria Mattio, Lorenzo Cangiano, Giancarlo Marenzi



Bivariate random-effects models for the meta-analysis of rare events

Danyu Li, Patrick Taffe



Time-varying Decomposition of Direct and Indirect Effects with Multiple Longitudinal Mediators

Yasuyuki Okuda, Masataka Taguri



Causal framework for analyzing mediation effects of clinical biomarkers

Jinesh Shah



A Modified Doubly Robust Estimator for Clustered Causal Inference: Integrating GLMM and GBM

Samina Naznin, Dr. Mohaimen Monsur



DoubleMLDeep: Estimation of Causal Effects with Multimodal Data

Martin Spindler, Victor Chernozhukov, Philipp Bach, Jan Teichert-Kluge, Sven Klaassen, Suhas Vijaykumar



Causal Machine Learning Methods for Estimating Personalised Treatment Effects - Insights on validity from two large trials

Hongruyu Chen, Helena Aebersold, Milo Alan Puhan, Miquel Serra-Burriel



Challenges with subgroup analyses in individual participant data meta-analysis of randomised trials

Alain Amstutz, Dominique Costagliola, Corina S. Rueegg, Erica Ponzi, Johannes M. Schwenke, France Mentré, Clément R. Massonnaud, Cédric Laouénan, Aliou Baldé, Lambert Assoumou, Inge C. Olsen, Matthias Briel, Stefan Schandelmaier



Illustration and evaluation of a causal approach to sensitivity analysis for unmeasured confounding using measured proxies with a simulation study

Nerissa Nance, Romain Neugebauer



Quantifying causal treatment effect on binary outcome in RCTs with noncompliance: estimating risk difference, risk ratio and odds ratio

Junxian Zhu, Mark Y. Chan, Bee-Choo Tai



Blinded sample size recalculation for randomized controlled trials with analysis of covariance

Takumi Kanata, Yasuhiro Hagiwara, Koji Oba



Variance stabilization transformation for the intraclass correlation coefficient of agreement with an application example to meta-analyses of inter-rater reliability studies

Abderrahmane Bourredjem, Isabelle Fournel, Sophie Vanbelle, Nadjia El Saadi



Bridging Single Arm Studies with Individual Participant Data in Network Meta-Analysis of Randomized Controlled Trials: A Simulation Study

Katerina Maria Kontouli, Stavros Nikolakopoulos, Christos Christogiannis, Dimitrios Mavridis



Comparative Efficacy and Safety of Migraine Treatments: A Network Meta-Analysis of Clinical Outcomes

Shashank Tripathi, Rachna Agarwal



Optimal standardization as an alternative to matching using propensity scores

Ekkehard Glimm, Lillian Yau



Evaluating Diagnostic Tests Against Composite Reference Standards: Quantifying and Adjusting for Bias

Vera Hudak, Nicky J. Welton, Efthymia Derezea, Hayley Jones



Characteristics, Design and Statistical Methods in Platform Trials: A Systematic Review

Clément R. Massonnaud, Christof Manuel Schönenberger, Malena Chiaborelli, Selina Ehrenzeller, Alexandra Griessbach, André Gillibert, Matthias Briel, Cédric Laouénan



WRestimates: An R Package for Win-Ratio Sample Size and Power Calculations

Autumn O Donnell



Randomizing With Investigator Choice of Treatment: A Powerful Pragmatic Tool in Clinical Trials

Lillian Yau, Betty Molloy



Confirming assay sensitivity in 2-arm non-inferiority trial using meta-analytic-predictive approach

Satomi OKAMURA, Eisuke HIDA



Adding baskets to an ongoing basket trial with information borrowing: When do you benefit?

Libby Daniells, Pavel Mozgunov, Helen Barnett, Alun Bedding, Thomas Jaki



Optimizing Adaptive Trial Design to Ensure Robustness Across Varying Treatment Effect Assumptions

Valeria Mazzanti, Dirk Klingbiel



N-of-1 Trials to Estimate Individual Effects of Music on Concentration

Thomas Gärtner, Fabian Stolp, Stefan Konigorski



Simulation Study Examining Impact of Study Design Factors on Variability Measures

Laura Quinn, Jon Deeks, Yemisi Takwoingi, Alice Sitch



Simulation-based optimization of adaptive designs using a generalized version of assurance

Pantelis Vlachos, Valeria Mazzanti, Boaz Adler



Evaluating the impact of outcome delay on adaptive designs

Aritra Mukherjee, Michael J. Grayling, James M. S. Wason

11:00am
-
12:15pm
Statistical and causal perspectives on machine learning in estimating individualized treatment strategies
Erica E. M. Moodle
Biostatistics, McGill University, Canada
Location: Biozentrum U1.111
 

Erica E. M. Moodle

Statistical and causal perspectives on machine learning in estimating individualized treatment strategies
Location: Biozentrum U1.131, U1.141, U1.101 & ETH E27, E23, E21
Livestream of the plenary
 

Erica E. M. Moodle

12:15pm
-
1:30pm
ISCB Annual General Meeting
Location: Biozentrum U1.111
Poster Exhibition: W / Wednesday posters
Location: Poster Location
 

Exploring the Exposome correlated with Body Mass Index in Adolescents: Findings from the 2014-2015 and 2022-2023 KNHANES

Hye Ah Lee, Hyesook Park



Flexible statistical modeling of undernutrition among under-five children in India

SHAMBHAVI MISHRA



Comparison of deep learning models with different architectures and training populations for ECG age estimation: Accuracy, agreement, and CVD prediction

Arya Panthalanickal Vijayakumar, Tom Wilsgaard, Henrik Schirmer, Ernest Diez Benavente, René van Es, Rutger R. van de Leur, Haakon Lindekleiv, Zachi I. Attia, Francisco Lopez-Jimenez, David A. Leon, Olena Iakunchykova



Systematic review and real life-oriented evaluation on methods for feature selection in longitudinal biomedical data

Alexander Gieswinkel, Gregor Buch, Gökhan Gül, Vincent ten Cate, Lisa Hartung, Philipp S. Wild



How does acute exposure to environmental factors relate to stroke characteristics such as stroke type, severity, and impairments?

BOHAN ZHANG, Andy Vail, Craig Smith, Amit Kishore, Matthew Gittins



Improving TBI Prognosis in developing world: A Machine Learning-based AutoScore Approach to Predict Six-Month Functional Outcome

Vineet Kumar Kamal, Deepak Agrawal



Predictive Risk Index for Poor Cognitive Development Among Children Using Machine Learning Approaches

Anita Kerubo Ogero, Patricia Kipkemoi, Amina Abubakar



Development and validation of a model to predict ceiling of care in COVID-19 hospitalised patients

Natàlia Pallarès Fontanet, Hristo Inouzhe, Jordi Cortés, Sam Straw, Klaus K Witte, Jordi Carratalà, Sebastià Videla, Cristian Tebé



Transformer Models for Clinical Prediction – Investigation of BEHRT in UK Biobank and prediction assessment under different scenarios

Yusuf Yildiz, Goran Nenadic, Meghna Jani, David A. Jenkins



What is the best way to analyse ventilator-free days?

Laurent Renard Triché, Matthieu Jabaudon, Bruno Pereira, Sylvie Chevret



Compare Estimation and Classification Performances of Statistical Shrinkage Methods Ridge Regression, Lasso Regression, and Elastic Net Regression

Gamze Ozen, Fezan Mutlu



Defining Harm in Settings with Outcomes that are Not Binary

Amit Sawant, Mats Stensrud



Brier pseudo-observation score for selecting a multiplicative, an additive or an additive-multiplicative hazards regression model

François Lefebvre, Roch Giorgi



Bayesian spatio-temporal analysis of the COVID-19 pandemic in Catalonia

Pau Satorra, Cristian Tebé



A Simulation Study of Bayesian Approaches to Spatial Modelling Using the Besag-York-Mollie Model

Hollie Hughes, David Hughes



A Bayesian analysis of FINEARTS-HF

Alasdair D Henderson, Brian L Claggett, Akshay S Desai, Mutthiah Vaduganathan, Carolyn S Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Meike Brinker, Flaviana Amarante, Katja Rohwedder, James Lay-Flurrie, Scott D Solomon, John JV McMurray, Pardeep S Jhund



Fast Approximation of Joint Models: A Comparative Evaluation of Bayesian Methods

Jinghao Li, David M Hughes



Confidence Intervals for Comparing Two Independent Folded Normals

Eleonora Di Carluccio, Sarah Ogutu, Ozkan Köse, Henry G. Mwambi, Andreas Ziegler



Towards Realistic Synthetic Nanopore Protein Signals: A Comparative Study of Stochastic and GAN-Based Methods

Göran Köber, Jonas Bürgel, Tobias Ensslen, Oliver Amft



Data Transformations in Machine Learning Approaches for Studying Microbiota as a Biomarker of Non-Response Risk to CFTR Modulators

Marta Avalos, Céline Hosteins, Diego Kauer, Chloé Renault, Raphaël Enaud, Laurence Delhaes



On microbiome data analysis using Bayesian method under the assumption of a zero-inflated model

Yuki Ando, Asanao Shimokawa



Estimating prevalence of cystic fibrosis heterozygosity using Fast Boltzmann Inversion (FBI): An improved Monte Carlo algorithm for Bayesian inference

Jan Brink Valentin



A Sparse Graph Representation of Hi-C Data for Colorectal Cancer Prediction

Jiwon Im, Mingyu Go, Insu Jang, Minsu Park



A multi-state survival model for recurring adenomas in Lynch syndrome individuals

Vanessa García López-Mingo, Veerle Coupé, Marjolein Greuter, Thomas Klausch



Evaluating Completeness of Data in CPRD’s Breast Cancer Data: Implications for External Controls for Surrogate Endpoints

Dorcas N Kareithi, Jingky Lozano-Kuehne, David Sinclair, James Wason



Identification of risk factors for the development of de novo malignancies after liver transplantation

Tereza Hakova, Pavel Taimr, Tomáš Hucl, Zdeněk Valenta



Are ACE inhibitors associated with increased lung cancer risk, or are unmeasured confounders biasing results?

Sean Maguire, Ruth Keogh, Elizabeth Williamson, John Tazare



DO GENETIC CHANGES IN 15Q13.3 MEAN LOWER IQ SCORE?

Tadas Žvirblis, Pilar Caro, Audronė Jakaitienė, Christian Schaaf



Measuring the performance of survival models to personalize treatment choices

Orestis Efthimiou, Jeroen Hoogland, Thomas Debray, Valerie Aponte Ribero, Wilma Knol, Huiberdina Koek, Matthias Schwenkglenks, Séverine Henrard, Matthias Egger, Nicolas Rodondi, Ian White



A framework for estimating quality adjusted life years using joint models of longitudinal and survival data

Michael Crowther, Alessandro Gasparini, Sara Ekberg, Federico Felizzi, Elaine Gallagher, Noman Paracha



Cut Off Determination using Model Derived Estimate in Survival Prediction Model

Jungbok Lee



A two-step testing approach for comparing time-to-event data under non-proportional hazards

Jonas Brugger, Tim Friede, Florian Klinglmüller, Martin Posch, Franz König



A systematic review of Bayesian survival modelling for extrapolating survival in cost-effectiveness analysis

Farah Erdogan, Gwénaël Le Teuff



Power comparison of hazard ratio versus restricted mean survival time in the presence of cure

Ronald Bertus Geskus



Sample Size Calculation in Prognostic Studies: A Comparative Analysis

Gloria Brigiari, Ester Rosa, Giulia Lorenzoni, Dario Gregori



Prognostic Score Adjustment in a Two-Slope Mixed Effects Model to Estimate Treatment Effects on eGFR Slope in CKD Patients

Silke Janitza, Maike Ahrens, Sebastian Voss, Bohdana Ratitch, Nicole Rethemeier, Meike Brinker, Paula Vesterinen, Antigoni Elefsinioti



Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers to prevent or delay dementia: a target trial emulation

Marie-Laure Charpignon, Max Sunog, Colin Magdamo, Bella Vakulenko-Lagun, Ioanna Tzoulaki, Sudeshna Das, Deborah Blacker, Mark Albers



Optimal utility-based design of phase II/phase III programmes with different type of endpoints in the setting of multiple myeloma

Haotian Wang, Peter Kimani, Michael Grayling, Josephine Khan, Nigel Stallard



Beyond first events: Advancing recurrent adverse event estimates in clinical research.

Nicolas Sauvageot, Leen Slaets, Anirban Mitra, Zoe Craig, Jane Gilbert, Lilla Di Scala, Stefan Englert



Cure models to compare aftercare monitoring schemes in pediatric cancer

Ulrike Pötschger, Harm van Tinteren, Evgenia Glogova, Helga Arnardottir, Paulina Kurzmann, Sabine Taschner-Mandl, Lieve Titgat, Martina Mittlböck



Comparison of treatment sequences in advanced pancreatic cancer

Norbert Marschner, Nina Haug, Susanna Hegewisch-Becker, Marcel Reiser, Steffen Dörfel, Rüdiger Liersch, Hartmut Linde, Thomas Wolf, Anna Hof, Anja Kaiser-Osterhues, Karin Potthoff, Martina Jänicke



Clinical Trials with Time-to-event-endpoint: Interim Prediction of Number of Events with Confidence Distributions

Edoardo Ratti, Maria Grazia Valsecchi, Stefania Galimberti



A Bayesian-Informed Dose-Escalation Design for Multi-Cohort Oncology Trials with Varying Maximum Tolerated Doses

Martin Kappler, Yuan Ji



Comparison of Bayesian Approaches in Single-Agent Dose-Finding Studies

Vibha Srichand



Evaluating the effect of different non-informative prior specifications on the Bayesian proportional odds model in randomised controlled trials

Chris J Selman, Katherine J Lee, Michael Dymock, Ian Marschner, Steven Y.C. Tong, Mark Jones, Tom Snelling, Robert K Mahar



Bayesian decision analysis for clinical trial design with binary outcome in the context of Ebola Virus Disease outbreak – Simulation study

Drifa Belhadi, Joonhyuk Cho, Pauline Manchon, Denis Malvy, France Mentré, Andrew W Lo, Cédric Laouénan



Relevance of Electronic Medical Records for Clinical Trial Eligibility: A Feasibility Assessment in Acute Stroke Studies

Yusuke Sasahara, Taizo Murata, Yasufumi Gon, Toshihiro Takeda, Eisuke Hida



Navigating complex and computationally demanding clinical trial simulation

Saumil Shah, Mitchell Thomann



Transforming Clinical Trials: The Power of Synthetic Data in Augmenting Control Arms

Emmanuelle Boutmy, Shane O Meachair, Julie Zhang, Sabrina de Souza, Saheli Das, Dina Oksen, Anna Tafuri, Lucy Mosquera



Integrating stakeholder perspectives in modeling routine data for therapeutic decision-making

Michelle Pfaffenlehner, Andrea Dreßing, Dietrich Knoerzer, Markus Wagner, Peter Heuschmann, André Scherag, Harald Binder, Nadine Binder



Aligning Synthetic Trajectories from Expert-Based Models with Real Patient Data Using Low-Dimensional Representations

Hanning Yang, Meropi Karakioulaki, Cristina Has, Moritz Hess, Harald Binder



Integrating semantic information in care pathway studies with medical code embeddings, application to the case of Amyotrophic Lateral Sclerosis

Corentin FAUJOUR, Stéphane BOUEE, Corinne EMERY, Anne-Sophie JANNOT



Inequalities in impact of respiratory viruses: development and analysis of respiratory virus phenotypes in EHRs from England using OpenSAFELY

Em Prestige, Jennifer K. Quint, Charlotte Warren-Gash, William Hulme, Edward PK Parker, Elizabeth Williamson, Rosalind M. Eggo



Modeling Longitudinal Clinical Outcomes: Comparison of Generalized Linear Models, Generalized Estimating Equations, and Marginalized Multilevel Models in Pediatric Intensive Care

Luca Vedovelli, Stefania Lando, Danila Azzolina, Corrado Lanera, Ileana Baldi, Dario Gregori



Modelling the costeffectiveness of Truvada for the Prevention of Mother to Child Prevention (PMTCT) of Hepatitis B Virus in Botswana

Graceful Mulenga, Motswedi Anderson, Simani Gaseitsiwe



Application of machine learning methods for the analysis of randomised controlled trials: A systematic review

Xiao Xuan Tan, Rachel Phillips, Mansour Taghavi Azar Sharabiani



Joint longitudinal modelling of non-normally distributed outcomes and endogenous covariates

Chiara Degan, Bart Mertens, Pietro Spitali, Erik H. Niks, Jelle Goeman, Roula Tsonaka



Mediation analysis for exploring gender differences in mortality among acute myocardial infarction

Alice Bonomi, Arianna Galotta, Francesco Maria Mattio, Lorenzo Cangiano, Giancarlo Marenzi



Bivariate random-effects models for the meta-analysis of rare events

Danyu Li, Patrick Taffe



Time-varying Decomposition of Direct and Indirect Effects with Multiple Longitudinal Mediators

Yasuyuki Okuda, Masataka Taguri



Causal framework for analyzing mediation effects of clinical biomarkers

Jinesh Shah



A Modified Doubly Robust Estimator for Clustered Causal Inference: Integrating GLMM and GBM

Samina Naznin, Dr. Mohaimen Monsur



DoubleMLDeep: Estimation of Causal Effects with Multimodal Data

Martin Spindler, Victor Chernozhukov, Philipp Bach, Jan Teichert-Kluge, Sven Klaassen, Suhas Vijaykumar



Causal Machine Learning Methods for Estimating Personalised Treatment Effects - Insights on validity from two large trials

Hongruyu Chen, Helena Aebersold, Milo Alan Puhan, Miquel Serra-Burriel



Challenges with subgroup analyses in individual participant data meta-analysis of randomised trials

Alain Amstutz, Dominique Costagliola, Corina S. Rueegg, Erica Ponzi, Johannes M. Schwenke, France Mentré, Clément R. Massonnaud, Cédric Laouénan, Aliou Baldé, Lambert Assoumou, Inge C. Olsen, Matthias Briel, Stefan Schandelmaier



Illustration and evaluation of a causal approach to sensitivity analysis for unmeasured confounding using measured proxies with a simulation study

Nerissa Nance, Romain Neugebauer



Quantifying causal treatment effect on binary outcome in RCTs with noncompliance: estimating risk difference, risk ratio and odds ratio

Junxian Zhu, Mark Y. Chan, Bee-Choo Tai



Blinded sample size recalculation for randomized controlled trials with analysis of covariance

Takumi Kanata, Yasuhiro Hagiwara, Koji Oba



Variance stabilization transformation for the intraclass correlation coefficient of agreement with an application example to meta-analyses of inter-rater reliability studies

Abderrahmane Bourredjem, Isabelle Fournel, Sophie Vanbelle, Nadjia El Saadi



Bridging Single Arm Studies with Individual Participant Data in Network Meta-Analysis of Randomized Controlled Trials: A Simulation Study

Katerina Maria Kontouli, Stavros Nikolakopoulos, Christos Christogiannis, Dimitrios Mavridis



Comparative Efficacy and Safety of Migraine Treatments: A Network Meta-Analysis of Clinical Outcomes

Shashank Tripathi, Rachna Agarwal



Optimal standardization as an alternative to matching using propensity scores

Ekkehard Glimm, Lillian Yau



Evaluating Diagnostic Tests Against Composite Reference Standards: Quantifying and Adjusting for Bias

Vera Hudak, Nicky J. Welton, Efthymia Derezea, Hayley Jones



Characteristics, Design and Statistical Methods in Platform Trials: A Systematic Review

Clément R. Massonnaud, Christof Manuel Schönenberger, Malena Chiaborelli, Selina Ehrenzeller, Alexandra Griessbach, André Gillibert, Matthias Briel, Cédric Laouénan



WRestimates: An R Package for Win-Ratio Sample Size and Power Calculations

Autumn O Donnell



Randomizing With Investigator Choice of Treatment: A Powerful Pragmatic Tool in Clinical Trials

Lillian Yau, Betty Molloy



Confirming assay sensitivity in 2-arm non-inferiority trial using meta-analytic-predictive approach

Satomi OKAMURA, Eisuke HIDA



Adding baskets to an ongoing basket trial with information borrowing: When do you benefit?

Libby Daniells, Pavel Mozgunov, Helen Barnett, Alun Bedding, Thomas Jaki



Optimizing Adaptive Trial Design to Ensure Robustness Across Varying Treatment Effect Assumptions

Valeria Mazzanti, Dirk Klingbiel



N-of-1 Trials to Estimate Individual Effects of Music on Concentration

Thomas Gärtner, Fabian Stolp, Stefan Konigorski



Simulation Study Examining Impact of Study Design Factors on Variability Measures

Laura Quinn, Jon Deeks, Yemisi Takwoingi, Alice Sitch



Simulation-based optimization of adaptive designs using a generalized version of assurance

Pantelis Vlachos, Valeria Mazzanti, Boaz Adler



Evaluating the impact of outcome delay on adaptive designs

Aritra Mukherjee, Michael J. Grayling, James M. S. Wason

1:00pm
-
2:00pm
Lunch
Poster Exhibition: W / Wednesday posters
Location: Poster Location
 

Exploring the Exposome correlated with Body Mass Index in Adolescents: Findings from the 2014-2015 and 2022-2023 KNHANES

Hye Ah Lee, Hyesook Park



Flexible statistical modeling of undernutrition among under-five children in India

SHAMBHAVI MISHRA



Comparison of deep learning models with different architectures and training populations for ECG age estimation: Accuracy, agreement, and CVD prediction

Arya Panthalanickal Vijayakumar, Tom Wilsgaard, Henrik Schirmer, Ernest Diez Benavente, René van Es, Rutger R. van de Leur, Haakon Lindekleiv, Zachi I. Attia, Francisco Lopez-Jimenez, David A. Leon, Olena Iakunchykova



Systematic review and real life-oriented evaluation on methods for feature selection in longitudinal biomedical data

Alexander Gieswinkel, Gregor Buch, Gökhan Gül, Vincent ten Cate, Lisa Hartung, Philipp S. Wild



How does acute exposure to environmental factors relate to stroke characteristics such as stroke type, severity, and impairments?

BOHAN ZHANG, Andy Vail, Craig Smith, Amit Kishore, Matthew Gittins



Improving TBI Prognosis in developing world: A Machine Learning-based AutoScore Approach to Predict Six-Month Functional Outcome

Vineet Kumar Kamal, Deepak Agrawal



Predictive Risk Index for Poor Cognitive Development Among Children Using Machine Learning Approaches

Anita Kerubo Ogero, Patricia Kipkemoi, Amina Abubakar



Development and validation of a model to predict ceiling of care in COVID-19 hospitalised patients

Natàlia Pallarès Fontanet, Hristo Inouzhe, Jordi Cortés, Sam Straw, Klaus K Witte, Jordi Carratalà, Sebastià Videla, Cristian Tebé



Transformer Models for Clinical Prediction – Investigation of BEHRT in UK Biobank and prediction assessment under different scenarios

Yusuf Yildiz, Goran Nenadic, Meghna Jani, David A. Jenkins



What is the best way to analyse ventilator-free days?

Laurent Renard Triché, Matthieu Jabaudon, Bruno Pereira, Sylvie Chevret



Compare Estimation and Classification Performances of Statistical Shrinkage Methods Ridge Regression, Lasso Regression, and Elastic Net Regression

Gamze Ozen, Fezan Mutlu



Defining Harm in Settings with Outcomes that are Not Binary

Amit Sawant, Mats Stensrud



Brier pseudo-observation score for selecting a multiplicative, an additive or an additive-multiplicative hazards regression model

François Lefebvre, Roch Giorgi



Bayesian spatio-temporal analysis of the COVID-19 pandemic in Catalonia

Pau Satorra, Cristian Tebé



A Simulation Study of Bayesian Approaches to Spatial Modelling Using the Besag-York-Mollie Model

Hollie Hughes, David Hughes



A Bayesian analysis of FINEARTS-HF

Alasdair D Henderson, Brian L Claggett, Akshay S Desai, Mutthiah Vaduganathan, Carolyn S Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Meike Brinker, Flaviana Amarante, Katja Rohwedder, James Lay-Flurrie, Scott D Solomon, John JV McMurray, Pardeep S Jhund



Fast Approximation of Joint Models: A Comparative Evaluation of Bayesian Methods

Jinghao Li, David M Hughes



Confidence Intervals for Comparing Two Independent Folded Normals

Eleonora Di Carluccio, Sarah Ogutu, Ozkan Köse, Henry G. Mwambi, Andreas Ziegler



Towards Realistic Synthetic Nanopore Protein Signals: A Comparative Study of Stochastic and GAN-Based Methods

Göran Köber, Jonas Bürgel, Tobias Ensslen, Oliver Amft



Data Transformations in Machine Learning Approaches for Studying Microbiota as a Biomarker of Non-Response Risk to CFTR Modulators

Marta Avalos, Céline Hosteins, Diego Kauer, Chloé Renault, Raphaël Enaud, Laurence Delhaes



On microbiome data analysis using Bayesian method under the assumption of a zero-inflated model

Yuki Ando, Asanao Shimokawa



Estimating prevalence of cystic fibrosis heterozygosity using Fast Boltzmann Inversion (FBI): An improved Monte Carlo algorithm for Bayesian inference

Jan Brink Valentin



A Sparse Graph Representation of Hi-C Data for Colorectal Cancer Prediction

Jiwon Im, Mingyu Go, Insu Jang, Minsu Park



A multi-state survival model for recurring adenomas in Lynch syndrome individuals

Vanessa García López-Mingo, Veerle Coupé, Marjolein Greuter, Thomas Klausch



Evaluating Completeness of Data in CPRD’s Breast Cancer Data: Implications for External Controls for Surrogate Endpoints

Dorcas N Kareithi, Jingky Lozano-Kuehne, David Sinclair, James Wason



Identification of risk factors for the development of de novo malignancies after liver transplantation

Tereza Hakova, Pavel Taimr, Tomáš Hucl, Zdeněk Valenta



Are ACE inhibitors associated with increased lung cancer risk, or are unmeasured confounders biasing results?

Sean Maguire, Ruth Keogh, Elizabeth Williamson, John Tazare



DO GENETIC CHANGES IN 15Q13.3 MEAN LOWER IQ SCORE?

Tadas Žvirblis, Pilar Caro, Audronė Jakaitienė, Christian Schaaf



Measuring the performance of survival models to personalize treatment choices

Orestis Efthimiou, Jeroen Hoogland, Thomas Debray, Valerie Aponte Ribero, Wilma Knol, Huiberdina Koek, Matthias Schwenkglenks, Séverine Henrard, Matthias Egger, Nicolas Rodondi, Ian White



A framework for estimating quality adjusted life years using joint models of longitudinal and survival data

Michael Crowther, Alessandro Gasparini, Sara Ekberg, Federico Felizzi, Elaine Gallagher, Noman Paracha



Cut Off Determination using Model Derived Estimate in Survival Prediction Model

Jungbok Lee



A two-step testing approach for comparing time-to-event data under non-proportional hazards

Jonas Brugger, Tim Friede, Florian Klinglmüller, Martin Posch, Franz König



A systematic review of Bayesian survival modelling for extrapolating survival in cost-effectiveness analysis

Farah Erdogan, Gwénaël Le Teuff



Power comparison of hazard ratio versus restricted mean survival time in the presence of cure

Ronald Bertus Geskus



Sample Size Calculation in Prognostic Studies: A Comparative Analysis

Gloria Brigiari, Ester Rosa, Giulia Lorenzoni, Dario Gregori



Prognostic Score Adjustment in a Two-Slope Mixed Effects Model to Estimate Treatment Effects on eGFR Slope in CKD Patients

Silke Janitza, Maike Ahrens, Sebastian Voss, Bohdana Ratitch, Nicole Rethemeier, Meike Brinker, Paula Vesterinen, Antigoni Elefsinioti



Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers to prevent or delay dementia: a target trial emulation

Marie-Laure Charpignon, Max Sunog, Colin Magdamo, Bella Vakulenko-Lagun, Ioanna Tzoulaki, Sudeshna Das, Deborah Blacker, Mark Albers



Optimal utility-based design of phase II/phase III programmes with different type of endpoints in the setting of multiple myeloma

Haotian Wang, Peter Kimani, Michael Grayling, Josephine Khan, Nigel Stallard



Beyond first events: Advancing recurrent adverse event estimates in clinical research.

Nicolas Sauvageot, Leen Slaets, Anirban Mitra, Zoe Craig, Jane Gilbert, Lilla Di Scala, Stefan Englert



Cure models to compare aftercare monitoring schemes in pediatric cancer

Ulrike Pötschger, Harm van Tinteren, Evgenia Glogova, Helga Arnardottir, Paulina Kurzmann, Sabine Taschner-Mandl, Lieve Titgat, Martina Mittlböck



Comparison of treatment sequences in advanced pancreatic cancer

Norbert Marschner, Nina Haug, Susanna Hegewisch-Becker, Marcel Reiser, Steffen Dörfel, Rüdiger Liersch, Hartmut Linde, Thomas Wolf, Anna Hof, Anja Kaiser-Osterhues, Karin Potthoff, Martina Jänicke



Clinical Trials with Time-to-event-endpoint: Interim Prediction of Number of Events with Confidence Distributions

Edoardo Ratti, Maria Grazia Valsecchi, Stefania Galimberti



A Bayesian-Informed Dose-Escalation Design for Multi-Cohort Oncology Trials with Varying Maximum Tolerated Doses

Martin Kappler, Yuan Ji



Comparison of Bayesian Approaches in Single-Agent Dose-Finding Studies

Vibha Srichand



Evaluating the effect of different non-informative prior specifications on the Bayesian proportional odds model in randomised controlled trials

Chris J Selman, Katherine J Lee, Michael Dymock, Ian Marschner, Steven Y.C. Tong, Mark Jones, Tom Snelling, Robert K Mahar



Bayesian decision analysis for clinical trial design with binary outcome in the context of Ebola Virus Disease outbreak – Simulation study

Drifa Belhadi, Joonhyuk Cho, Pauline Manchon, Denis Malvy, France Mentré, Andrew W Lo, Cédric Laouénan



Relevance of Electronic Medical Records for Clinical Trial Eligibility: A Feasibility Assessment in Acute Stroke Studies

Yusuke Sasahara, Taizo Murata, Yasufumi Gon, Toshihiro Takeda, Eisuke Hida



Navigating complex and computationally demanding clinical trial simulation

Saumil Shah, Mitchell Thomann



Transforming Clinical Trials: The Power of Synthetic Data in Augmenting Control Arms

Emmanuelle Boutmy, Shane O Meachair, Julie Zhang, Sabrina de Souza, Saheli Das, Dina Oksen, Anna Tafuri, Lucy Mosquera



Integrating stakeholder perspectives in modeling routine data for therapeutic decision-making

Michelle Pfaffenlehner, Andrea Dreßing, Dietrich Knoerzer, Markus Wagner, Peter Heuschmann, André Scherag, Harald Binder, Nadine Binder



Aligning Synthetic Trajectories from Expert-Based Models with Real Patient Data Using Low-Dimensional Representations

Hanning Yang, Meropi Karakioulaki, Cristina Has, Moritz Hess, Harald Binder



Integrating semantic information in care pathway studies with medical code embeddings, application to the case of Amyotrophic Lateral Sclerosis

Corentin FAUJOUR, Stéphane BOUEE, Corinne EMERY, Anne-Sophie JANNOT



Inequalities in impact of respiratory viruses: development and analysis of respiratory virus phenotypes in EHRs from England using OpenSAFELY

Em Prestige, Jennifer K. Quint, Charlotte Warren-Gash, William Hulme, Edward PK Parker, Elizabeth Williamson, Rosalind M. Eggo



Modeling Longitudinal Clinical Outcomes: Comparison of Generalized Linear Models, Generalized Estimating Equations, and Marginalized Multilevel Models in Pediatric Intensive Care

Luca Vedovelli, Stefania Lando, Danila Azzolina, Corrado Lanera, Ileana Baldi, Dario Gregori



Modelling the costeffectiveness of Truvada for the Prevention of Mother to Child Prevention (PMTCT) of Hepatitis B Virus in Botswana

Graceful Mulenga, Motswedi Anderson, Simani Gaseitsiwe



Application of machine learning methods for the analysis of randomised controlled trials: A systematic review

Xiao Xuan Tan, Rachel Phillips, Mansour Taghavi Azar Sharabiani



Joint longitudinal modelling of non-normally distributed outcomes and endogenous covariates

Chiara Degan, Bart Mertens, Pietro Spitali, Erik H. Niks, Jelle Goeman, Roula Tsonaka



Mediation analysis for exploring gender differences in mortality among acute myocardial infarction

Alice Bonomi, Arianna Galotta, Francesco Maria Mattio, Lorenzo Cangiano, Giancarlo Marenzi



Bivariate random-effects models for the meta-analysis of rare events

Danyu Li, Patrick Taffe



Time-varying Decomposition of Direct and Indirect Effects with Multiple Longitudinal Mediators

Yasuyuki Okuda, Masataka Taguri



Causal framework for analyzing mediation effects of clinical biomarkers

Jinesh Shah



A Modified Doubly Robust Estimator for Clustered Causal Inference: Integrating GLMM and GBM

Samina Naznin, Dr. Mohaimen Monsur



DoubleMLDeep: Estimation of Causal Effects with Multimodal Data

Martin Spindler, Victor Chernozhukov, Philipp Bach, Jan Teichert-Kluge, Sven Klaassen, Suhas Vijaykumar



Causal Machine Learning Methods for Estimating Personalised Treatment Effects - Insights on validity from two large trials

Hongruyu Chen, Helena Aebersold, Milo Alan Puhan, Miquel Serra-Burriel



Challenges with subgroup analyses in individual participant data meta-analysis of randomised trials

Alain Amstutz, Dominique Costagliola, Corina S. Rueegg, Erica Ponzi, Johannes M. Schwenke, France Mentré, Clément R. Massonnaud, Cédric Laouénan, Aliou Baldé, Lambert Assoumou, Inge C. Olsen, Matthias Briel, Stefan Schandelmaier



Illustration and evaluation of a causal approach to sensitivity analysis for unmeasured confounding using measured proxies with a simulation study

Nerissa Nance, Romain Neugebauer



Quantifying causal treatment effect on binary outcome in RCTs with noncompliance: estimating risk difference, risk ratio and odds ratio

Junxian Zhu, Mark Y. Chan, Bee-Choo Tai



Blinded sample size recalculation for randomized controlled trials with analysis of covariance

Takumi Kanata, Yasuhiro Hagiwara, Koji Oba



Variance stabilization transformation for the intraclass correlation coefficient of agreement with an application example to meta-analyses of inter-rater reliability studies

Abderrahmane Bourredjem, Isabelle Fournel, Sophie Vanbelle, Nadjia El Saadi



Bridging Single Arm Studies with Individual Participant Data in Network Meta-Analysis of Randomized Controlled Trials: A Simulation Study

Katerina Maria Kontouli, Stavros Nikolakopoulos, Christos Christogiannis, Dimitrios Mavridis



Comparative Efficacy and Safety of Migraine Treatments: A Network Meta-Analysis of Clinical Outcomes

Shashank Tripathi, Rachna Agarwal



Optimal standardization as an alternative to matching using propensity scores

Ekkehard Glimm, Lillian Yau



Evaluating Diagnostic Tests Against Composite Reference Standards: Quantifying and Adjusting for Bias

Vera Hudak, Nicky J. Welton, Efthymia Derezea, Hayley Jones



Characteristics, Design and Statistical Methods in Platform Trials: A Systematic Review

Clément R. Massonnaud, Christof Manuel Schönenberger, Malena Chiaborelli, Selina Ehrenzeller, Alexandra Griessbach, André Gillibert, Matthias Briel, Cédric Laouénan



WRestimates: An R Package for Win-Ratio Sample Size and Power Calculations

Autumn O Donnell



Randomizing With Investigator Choice of Treatment: A Powerful Pragmatic Tool in Clinical Trials

Lillian Yau, Betty Molloy



Confirming assay sensitivity in 2-arm non-inferiority trial using meta-analytic-predictive approach

Satomi OKAMURA, Eisuke HIDA



Adding baskets to an ongoing basket trial with information borrowing: When do you benefit?

Libby Daniells, Pavel Mozgunov, Helen Barnett, Alun Bedding, Thomas Jaki



Optimizing Adaptive Trial Design to Ensure Robustness Across Varying Treatment Effect Assumptions

Valeria Mazzanti, Dirk Klingbiel



N-of-1 Trials to Estimate Individual Effects of Music on Concentration

Thomas Gärtner, Fabian Stolp, Stefan Konigorski



Simulation Study Examining Impact of Study Design Factors on Variability Measures

Laura Quinn, Jon Deeks, Yemisi Takwoingi, Alice Sitch



Simulation-based optimization of adaptive designs using a generalized version of assurance

Pantelis Vlachos, Valeria Mazzanti, Boaz Adler



Evaluating the impact of outcome delay on adaptive designs

Aritra Mukherjee, Michael J. Grayling, James M. S. Wason

2:00pm
-
3:30pm
Improving replicability in clinical biostatistics
Location: Biozentrum U1.111
 

Questionable Research Practices - From Small Errors to Research Misconduct

Leonhard Held



Improving the replicability of applied and methodological research

Sabine Hoffmann



Method benchmarking in computational biology - current state and future perspectives

Charlotte Soneson



Software sensitivity analysis in medical and methodological research

Tim P. Morris

Randomization and analysis of clinical trials
Location: Biozentrum U1.131
 

Distributive randomization: a pragmatic design to evaluate multiple simultaneous interventions in a clinical trial

Skerdi Haviari, France Mentré



Forced Randomisation – a powerful, sometimes controversial, tool for multi-centre RCTs

Johannes Krisam, Kerstine Carter, Olga Kuznetsova, Volodymyr Anisimov, Colin Scherer, Yevgen Ryeznik, Oleksandr Sverdlov



Type I error rate control in adaptive platform trials when including non-concurrent controls in the presence of time trend

Jinyu Zhu, Peter Kimani, Nigel Stallard, Andy Metcalfe, Jeremy Chataway, Keith Abrams



Data-driven controlled subgroup selection in clinical trials

Manuel M. Müller, Konstantinos Sechidis, Björn Bornkamp, Frank Bretz, Fang Wan, Wei Liu, Henry W. J. Reeve, Timothy I. Cannings, Richard J. Samworth



Debunking the myth: Random block sizes do not decrease selection biases in open-label clinical trials

Wenle Zhao

Survival analysis 2
Location: Biozentrum U1.141
 

A framework for estimating, investigating and using the correlation between multiple time-to-event endpoints in a group sequential trial

Anne Lyngholm Soerensen, Paul Blanche, Henrik Ravn, Christian Pipper



Likelihood adaptively incorporated external aggregate information with uncertainty for survival data

Jing Ning



A new statistical test to compare probability of being in response (PBR) with application to a study in oncology

Norbert Hollaender, Ekkehard Glimm



One-sample survival tests for non-proportional hazards in oncology clinical trials

Chloé Szurewsky, Guosheng Yin, Gwénaël Le Teuff



Efficiency of Nonparametric Superiority Tests Based on Restricted Mean Survival Time Versus the Logrank Test Under Proportional Hazards

Dominic Magirr

Causal inference: Mixed topics
Location: Biozentrum U1.101
 

Establishing when to use causal machine learning for conditional average treatment effect estimation in randomised controlled trials using simulation

Eleanor Van Vogt, Suzie Cro, Karla Diaz-Ordaz



Variable selection in Causal Survival Analysis

Charlotte Voinot, Julie Josse, Bernard Sebastien



An Overlooked Stability Property of the Risk Ratio and Its Practical Implications

Marco Piccininni, Mats J. Stensrud



Introducing an open access simulated benchmarking data resource to enable assessment and neutral comparison of causal inference methods

Ruth Keogh, Nan van Geloven, Daniala Weir



Simulating data from marginal structural models for a survival time outcome

Shaun Seaman, Ruth Keogh

Innovation in oncology dose escalation trials and beyond
Location: ETH E27
 

Declaring Doses as Safe in Ongoing Oncology Dose-Escalation Trials: Are They Truly Safe? A Critical Assessment of Safety Criteria

Stefan Englert, Thomas J. Prior, Anirban Mitra, Busola Sanusi, Liangcai Zhang, Lilla Di Scala



Guiding Phase I Dose Escalation for Modern Oncology Therapies: Tackling (Informative) Dropout with Bayesian Multi-Cycle Time-to-Event Models

Lukas Andreas Widmer, Sebastian Weber



Potential Responses and the Order of Patient Inclusion in Early-Phase Sequential Trials.

Meliha Akouba, Matthieu Clertant, Alexia Iasonos, John O'quigley



How best to allocate backfill patients in dose-finding oncology trials: a methodological review & simulation studies assessing best performance

Elli Bourmpaki, Helen Barnett, Oliver Boix, Hakim-Moulay Dehbi



Dose optimisation in early phase oncology trials - backfill and expansion cohorts

James Willard, Thomas Jaki, Burak Kürsad Günhan, Christina Habermehl, Anja Victor, Pavel Mozgunov

Missing data and imputation
Location: ETH E23
 

Missing value imputation methods in prediction model development: a neutral comparison of approaches

Manja Deforth, Georg Heinze, Ulrike Held



Assessing the Impact of Percentage of Missing Data and Imputation Methods on Youden Index Estimation

Sergio Sabroso-Lasa, Luis Mariano Esteban, Tomás Alcalá-Nalvaiz, Núria Malats



Recorded Reasons of Missingness-Informed Sensitivity Analyses in Clinical Trials

Dries Reynders, Jammbe Musoro, Saskia le Cessie, Els Goetghebeur



Adjusting for outcome reporting bias in meta-analysis: a multiple imputation approach

Cora Burgwinkel, Leonhard Held



Comparing Estimation Methods for Expected Quality of Life and Predicted Patient-Specific Trajectories in oncology: Addressing missingness/death (not) at random

Eline Vanderpijpen, Els Goetghebeur

Observational/real-world data 1
Location: ETH E21
 

Handling informative patient monitoring in routinely-collected data used to estimate treatment effects, with application to high-frequency hospital data

Leah Pirondini, Karla Diaz-Ordaz, Ruth Keogh



Target Trial Emulation to Duplicate Randomized Clinical Trials using Registry Data in Multiple Sclerosis

Antoine Gavoille, Mikail Nourredine, Fabien Rollot, Romain Casey, Sandra Vukusic, Muriel Rabilloud, Fabien Subtil



Exploring Synthetic Control Data Quality Between Data Types in Two Case Studies: COVID-19 and Crohn’s Disease

Nicole Ann Cizauskas, Svetlana Cherlin, James Wason



The most appropriate method for outlier detection in a clinical audit depends on the data distribution

Anqi Sui, Menelaos Pavlou, Rumana Z. Omar, Gareth Ambler



Incorporating real-world data to refine the calculation of probability of success

Bergas Fayyad, Laura Rodwell, Kit Roes, Giulia Ferrannini, Christian Basile, Lars Lund, Gianluigi Savarese, Aysun Cetinyurek-Yavuz

Poster Exhibition: W / Wednesday posters
Location: Poster Location
 

Exploring the Exposome correlated with Body Mass Index in Adolescents: Findings from the 2014-2015 and 2022-2023 KNHANES

Hye Ah Lee, Hyesook Park



Flexible statistical modeling of undernutrition among under-five children in India

SHAMBHAVI MISHRA



Comparison of deep learning models with different architectures and training populations for ECG age estimation: Accuracy, agreement, and CVD prediction

Arya Panthalanickal Vijayakumar, Tom Wilsgaard, Henrik Schirmer, Ernest Diez Benavente, René van Es, Rutger R. van de Leur, Haakon Lindekleiv, Zachi I. Attia, Francisco Lopez-Jimenez, David A. Leon, Olena Iakunchykova



Systematic review and real life-oriented evaluation on methods for feature selection in longitudinal biomedical data

Alexander Gieswinkel, Gregor Buch, Gökhan Gül, Vincent ten Cate, Lisa Hartung, Philipp S. Wild



How does acute exposure to environmental factors relate to stroke characteristics such as stroke type, severity, and impairments?

BOHAN ZHANG, Andy Vail, Craig Smith, Amit Kishore, Matthew Gittins



Improving TBI Prognosis in developing world: A Machine Learning-based AutoScore Approach to Predict Six-Month Functional Outcome

Vineet Kumar Kamal, Deepak Agrawal



Predictive Risk Index for Poor Cognitive Development Among Children Using Machine Learning Approaches

Anita Kerubo Ogero, Patricia Kipkemoi, Amina Abubakar



Development and validation of a model to predict ceiling of care in COVID-19 hospitalised patients

Natàlia Pallarès Fontanet, Hristo Inouzhe, Jordi Cortés, Sam Straw, Klaus K Witte, Jordi Carratalà, Sebastià Videla, Cristian Tebé



Transformer Models for Clinical Prediction – Investigation of BEHRT in UK Biobank and prediction assessment under different scenarios

Yusuf Yildiz, Goran Nenadic, Meghna Jani, David A. Jenkins



What is the best way to analyse ventilator-free days?

Laurent Renard Triché, Matthieu Jabaudon, Bruno Pereira, Sylvie Chevret



Compare Estimation and Classification Performances of Statistical Shrinkage Methods Ridge Regression, Lasso Regression, and Elastic Net Regression

Gamze Ozen, Fezan Mutlu



Defining Harm in Settings with Outcomes that are Not Binary

Amit Sawant, Mats Stensrud



Brier pseudo-observation score for selecting a multiplicative, an additive or an additive-multiplicative hazards regression model

François Lefebvre, Roch Giorgi



Bayesian spatio-temporal analysis of the COVID-19 pandemic in Catalonia

Pau Satorra, Cristian Tebé



A Simulation Study of Bayesian Approaches to Spatial Modelling Using the Besag-York-Mollie Model

Hollie Hughes, David Hughes



A Bayesian analysis of FINEARTS-HF

Alasdair D Henderson, Brian L Claggett, Akshay S Desai, Mutthiah Vaduganathan, Carolyn S Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Meike Brinker, Flaviana Amarante, Katja Rohwedder, James Lay-Flurrie, Scott D Solomon, John JV McMurray, Pardeep S Jhund



Fast Approximation of Joint Models: A Comparative Evaluation of Bayesian Methods

Jinghao Li, David M Hughes



Confidence Intervals for Comparing Two Independent Folded Normals

Eleonora Di Carluccio, Sarah Ogutu, Ozkan Köse, Henry G. Mwambi, Andreas Ziegler



Towards Realistic Synthetic Nanopore Protein Signals: A Comparative Study of Stochastic and GAN-Based Methods

Göran Köber, Jonas Bürgel, Tobias Ensslen, Oliver Amft



Data Transformations in Machine Learning Approaches for Studying Microbiota as a Biomarker of Non-Response Risk to CFTR Modulators

Marta Avalos, Céline Hosteins, Diego Kauer, Chloé Renault, Raphaël Enaud, Laurence Delhaes



On microbiome data analysis using Bayesian method under the assumption of a zero-inflated model

Yuki Ando, Asanao Shimokawa



Estimating prevalence of cystic fibrosis heterozygosity using Fast Boltzmann Inversion (FBI): An improved Monte Carlo algorithm for Bayesian inference

Jan Brink Valentin



A Sparse Graph Representation of Hi-C Data for Colorectal Cancer Prediction

Jiwon Im, Mingyu Go, Insu Jang, Minsu Park



A multi-state survival model for recurring adenomas in Lynch syndrome individuals

Vanessa García López-Mingo, Veerle Coupé, Marjolein Greuter, Thomas Klausch



Evaluating Completeness of Data in CPRD’s Breast Cancer Data: Implications for External Controls for Surrogate Endpoints

Dorcas N Kareithi, Jingky Lozano-Kuehne, David Sinclair, James Wason



Identification of risk factors for the development of de novo malignancies after liver transplantation

Tereza Hakova, Pavel Taimr, Tomáš Hucl, Zdeněk Valenta



Are ACE inhibitors associated with increased lung cancer risk, or are unmeasured confounders biasing results?

Sean Maguire, Ruth Keogh, Elizabeth Williamson, John Tazare



DO GENETIC CHANGES IN 15Q13.3 MEAN LOWER IQ SCORE?

Tadas Žvirblis, Pilar Caro, Audronė Jakaitienė, Christian Schaaf



Measuring the performance of survival models to personalize treatment choices

Orestis Efthimiou, Jeroen Hoogland, Thomas Debray, Valerie Aponte Ribero, Wilma Knol, Huiberdina Koek, Matthias Schwenkglenks, Séverine Henrard, Matthias Egger, Nicolas Rodondi, Ian White



A framework for estimating quality adjusted life years using joint models of longitudinal and survival data

Michael Crowther, Alessandro Gasparini, Sara Ekberg, Federico Felizzi, Elaine Gallagher, Noman Paracha



Cut Off Determination using Model Derived Estimate in Survival Prediction Model

Jungbok Lee



A two-step testing approach for comparing time-to-event data under non-proportional hazards

Jonas Brugger, Tim Friede, Florian Klinglmüller, Martin Posch, Franz König



A systematic review of Bayesian survival modelling for extrapolating survival in cost-effectiveness analysis

Farah Erdogan, Gwénaël Le Teuff



Power comparison of hazard ratio versus restricted mean survival time in the presence of cure

Ronald Bertus Geskus



Sample Size Calculation in Prognostic Studies: A Comparative Analysis

Gloria Brigiari, Ester Rosa, Giulia Lorenzoni, Dario Gregori



Prognostic Score Adjustment in a Two-Slope Mixed Effects Model to Estimate Treatment Effects on eGFR Slope in CKD Patients

Silke Janitza, Maike Ahrens, Sebastian Voss, Bohdana Ratitch, Nicole Rethemeier, Meike Brinker, Paula Vesterinen, Antigoni Elefsinioti



Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers to prevent or delay dementia: a target trial emulation

Marie-Laure Charpignon, Max Sunog, Colin Magdamo, Bella Vakulenko-Lagun, Ioanna Tzoulaki, Sudeshna Das, Deborah Blacker, Mark Albers



Optimal utility-based design of phase II/phase III programmes with different type of endpoints in the setting of multiple myeloma

Haotian Wang, Peter Kimani, Michael Grayling, Josephine Khan, Nigel Stallard



Beyond first events: Advancing recurrent adverse event estimates in clinical research.

Nicolas Sauvageot, Leen Slaets, Anirban Mitra, Zoe Craig, Jane Gilbert, Lilla Di Scala, Stefan Englert



Cure models to compare aftercare monitoring schemes in pediatric cancer

Ulrike Pötschger, Harm van Tinteren, Evgenia Glogova, Helga Arnardottir, Paulina Kurzmann, Sabine Taschner-Mandl, Lieve Titgat, Martina Mittlböck



Comparison of treatment sequences in advanced pancreatic cancer

Norbert Marschner, Nina Haug, Susanna Hegewisch-Becker, Marcel Reiser, Steffen Dörfel, Rüdiger Liersch, Hartmut Linde, Thomas Wolf, Anna Hof, Anja Kaiser-Osterhues, Karin Potthoff, Martina Jänicke



Clinical Trials with Time-to-event-endpoint: Interim Prediction of Number of Events with Confidence Distributions

Edoardo Ratti, Maria Grazia Valsecchi, Stefania Galimberti



A Bayesian-Informed Dose-Escalation Design for Multi-Cohort Oncology Trials with Varying Maximum Tolerated Doses

Martin Kappler, Yuan Ji



Comparison of Bayesian Approaches in Single-Agent Dose-Finding Studies

Vibha Srichand



Evaluating the effect of different non-informative prior specifications on the Bayesian proportional odds model in randomised controlled trials

Chris J Selman, Katherine J Lee, Michael Dymock, Ian Marschner, Steven Y.C. Tong, Mark Jones, Tom Snelling, Robert K Mahar



Bayesian decision analysis for clinical trial design with binary outcome in the context of Ebola Virus Disease outbreak – Simulation study

Drifa Belhadi, Joonhyuk Cho, Pauline Manchon, Denis Malvy, France Mentré, Andrew W Lo, Cédric Laouénan



Relevance of Electronic Medical Records for Clinical Trial Eligibility: A Feasibility Assessment in Acute Stroke Studies

Yusuke Sasahara, Taizo Murata, Yasufumi Gon, Toshihiro Takeda, Eisuke Hida



Navigating complex and computationally demanding clinical trial simulation

Saumil Shah, Mitchell Thomann



Transforming Clinical Trials: The Power of Synthetic Data in Augmenting Control Arms

Emmanuelle Boutmy, Shane O Meachair, Julie Zhang, Sabrina de Souza, Saheli Das, Dina Oksen, Anna Tafuri, Lucy Mosquera



Integrating stakeholder perspectives in modeling routine data for therapeutic decision-making

Michelle Pfaffenlehner, Andrea Dreßing, Dietrich Knoerzer, Markus Wagner, Peter Heuschmann, André Scherag, Harald Binder, Nadine Binder



Aligning Synthetic Trajectories from Expert-Based Models with Real Patient Data Using Low-Dimensional Representations

Hanning Yang, Meropi Karakioulaki, Cristina Has, Moritz Hess, Harald Binder



Integrating semantic information in care pathway studies with medical code embeddings, application to the case of Amyotrophic Lateral Sclerosis

Corentin FAUJOUR, Stéphane BOUEE, Corinne EMERY, Anne-Sophie JANNOT



Inequalities in impact of respiratory viruses: development and analysis of respiratory virus phenotypes in EHRs from England using OpenSAFELY

Em Prestige, Jennifer K. Quint, Charlotte Warren-Gash, William Hulme, Edward PK Parker, Elizabeth Williamson, Rosalind M. Eggo



Modeling Longitudinal Clinical Outcomes: Comparison of Generalized Linear Models, Generalized Estimating Equations, and Marginalized Multilevel Models in Pediatric Intensive Care

Luca Vedovelli, Stefania Lando, Danila Azzolina, Corrado Lanera, Ileana Baldi, Dario Gregori



Modelling the costeffectiveness of Truvada for the Prevention of Mother to Child Prevention (PMTCT) of Hepatitis B Virus in Botswana

Graceful Mulenga, Motswedi Anderson, Simani Gaseitsiwe



Application of machine learning methods for the analysis of randomised controlled trials: A systematic review

Xiao Xuan Tan, Rachel Phillips, Mansour Taghavi Azar Sharabiani



Joint longitudinal modelling of non-normally distributed outcomes and endogenous covariates

Chiara Degan, Bart Mertens, Pietro Spitali, Erik H. Niks, Jelle Goeman, Roula Tsonaka



Mediation analysis for exploring gender differences in mortality among acute myocardial infarction

Alice Bonomi, Arianna Galotta, Francesco Maria Mattio, Lorenzo Cangiano, Giancarlo Marenzi



Bivariate random-effects models for the meta-analysis of rare events

Danyu Li, Patrick Taffe



Time-varying Decomposition of Direct and Indirect Effects with Multiple Longitudinal Mediators

Yasuyuki Okuda, Masataka Taguri



Causal framework for analyzing mediation effects of clinical biomarkers

Jinesh Shah



A Modified Doubly Robust Estimator for Clustered Causal Inference: Integrating GLMM and GBM

Samina Naznin, Dr. Mohaimen Monsur



DoubleMLDeep: Estimation of Causal Effects with Multimodal Data

Martin Spindler, Victor Chernozhukov, Philipp Bach, Jan Teichert-Kluge, Sven Klaassen, Suhas Vijaykumar



Causal Machine Learning Methods for Estimating Personalised Treatment Effects - Insights on validity from two large trials

Hongruyu Chen, Helena Aebersold, Milo Alan Puhan, Miquel Serra-Burriel



Challenges with subgroup analyses in individual participant data meta-analysis of randomised trials

Alain Amstutz, Dominique Costagliola, Corina S. Rueegg, Erica Ponzi, Johannes M. Schwenke, France Mentré, Clément R. Massonnaud, Cédric Laouénan, Aliou Baldé, Lambert Assoumou, Inge C. Olsen, Matthias Briel, Stefan Schandelmaier



Illustration and evaluation of a causal approach to sensitivity analysis for unmeasured confounding using measured proxies with a simulation study

Nerissa Nance, Romain Neugebauer



Quantifying causal treatment effect on binary outcome in RCTs with noncompliance: estimating risk difference, risk ratio and odds ratio

Junxian Zhu, Mark Y. Chan, Bee-Choo Tai



Blinded sample size recalculation for randomized controlled trials with analysis of covariance

Takumi Kanata, Yasuhiro Hagiwara, Koji Oba



Variance stabilization transformation for the intraclass correlation coefficient of agreement with an application example to meta-analyses of inter-rater reliability studies

Abderrahmane Bourredjem, Isabelle Fournel, Sophie Vanbelle, Nadjia El Saadi



Bridging Single Arm Studies with Individual Participant Data in Network Meta-Analysis of Randomized Controlled Trials: A Simulation Study

Katerina Maria Kontouli, Stavros Nikolakopoulos, Christos Christogiannis, Dimitrios Mavridis



Comparative Efficacy and Safety of Migraine Treatments: A Network Meta-Analysis of Clinical Outcomes

Shashank Tripathi, Rachna Agarwal



Optimal standardization as an alternative to matching using propensity scores

Ekkehard Glimm, Lillian Yau



Evaluating Diagnostic Tests Against Composite Reference Standards: Quantifying and Adjusting for Bias

Vera Hudak, Nicky J. Welton, Efthymia Derezea, Hayley Jones



Characteristics, Design and Statistical Methods in Platform Trials: A Systematic Review

Clément R. Massonnaud, Christof Manuel Schönenberger, Malena Chiaborelli, Selina Ehrenzeller, Alexandra Griessbach, André Gillibert, Matthias Briel, Cédric Laouénan



WRestimates: An R Package for Win-Ratio Sample Size and Power Calculations

Autumn O Donnell



Randomizing With Investigator Choice of Treatment: A Powerful Pragmatic Tool in Clinical Trials

Lillian Yau, Betty Molloy



Confirming assay sensitivity in 2-arm non-inferiority trial using meta-analytic-predictive approach

Satomi OKAMURA, Eisuke HIDA



Adding baskets to an ongoing basket trial with information borrowing: When do you benefit?

Libby Daniells, Pavel Mozgunov, Helen Barnett, Alun Bedding, Thomas Jaki



Optimizing Adaptive Trial Design to Ensure Robustness Across Varying Treatment Effect Assumptions

Valeria Mazzanti, Dirk Klingbiel



N-of-1 Trials to Estimate Individual Effects of Music on Concentration

Thomas Gärtner, Fabian Stolp, Stefan Konigorski



Simulation Study Examining Impact of Study Design Factors on Variability Measures

Laura Quinn, Jon Deeks, Yemisi Takwoingi, Alice Sitch



Simulation-based optimization of adaptive designs using a generalized version of assurance

Pantelis Vlachos, Valeria Mazzanti, Boaz Adler



Evaluating the impact of outcome delay on adaptive designs

Aritra Mukherjee, Michael J. Grayling, James M. S. Wason

3:30pm
-
4:00pm
Coffee Break
Poster Exhibition: W / Wednesday posters
Location: Poster Location
 

Exploring the Exposome correlated with Body Mass Index in Adolescents: Findings from the 2014-2015 and 2022-2023 KNHANES

Hye Ah Lee, Hyesook Park



Flexible statistical modeling of undernutrition among under-five children in India

SHAMBHAVI MISHRA



Comparison of deep learning models with different architectures and training populations for ECG age estimation: Accuracy, agreement, and CVD prediction

Arya Panthalanickal Vijayakumar, Tom Wilsgaard, Henrik Schirmer, Ernest Diez Benavente, René van Es, Rutger R. van de Leur, Haakon Lindekleiv, Zachi I. Attia, Francisco Lopez-Jimenez, David A. Leon, Olena Iakunchykova



Systematic review and real life-oriented evaluation on methods for feature selection in longitudinal biomedical data

Alexander Gieswinkel, Gregor Buch, Gökhan Gül, Vincent ten Cate, Lisa Hartung, Philipp S. Wild



How does acute exposure to environmental factors relate to stroke characteristics such as stroke type, severity, and impairments?

BOHAN ZHANG, Andy Vail, Craig Smith, Amit Kishore, Matthew Gittins



Improving TBI Prognosis in developing world: A Machine Learning-based AutoScore Approach to Predict Six-Month Functional Outcome

Vineet Kumar Kamal, Deepak Agrawal



Predictive Risk Index for Poor Cognitive Development Among Children Using Machine Learning Approaches

Anita Kerubo Ogero, Patricia Kipkemoi, Amina Abubakar



Development and validation of a model to predict ceiling of care in COVID-19 hospitalised patients

Natàlia Pallarès Fontanet, Hristo Inouzhe, Jordi Cortés, Sam Straw, Klaus K Witte, Jordi Carratalà, Sebastià Videla, Cristian Tebé



Transformer Models for Clinical Prediction – Investigation of BEHRT in UK Biobank and prediction assessment under different scenarios

Yusuf Yildiz, Goran Nenadic, Meghna Jani, David A. Jenkins



What is the best way to analyse ventilator-free days?

Laurent Renard Triché, Matthieu Jabaudon, Bruno Pereira, Sylvie Chevret



Compare Estimation and Classification Performances of Statistical Shrinkage Methods Ridge Regression, Lasso Regression, and Elastic Net Regression

Gamze Ozen, Fezan Mutlu



Defining Harm in Settings with Outcomes that are Not Binary

Amit Sawant, Mats Stensrud



Brier pseudo-observation score for selecting a multiplicative, an additive or an additive-multiplicative hazards regression model

François Lefebvre, Roch Giorgi



Bayesian spatio-temporal analysis of the COVID-19 pandemic in Catalonia

Pau Satorra, Cristian Tebé



A Simulation Study of Bayesian Approaches to Spatial Modelling Using the Besag-York-Mollie Model

Hollie Hughes, David Hughes



A Bayesian analysis of FINEARTS-HF

Alasdair D Henderson, Brian L Claggett, Akshay S Desai, Mutthiah Vaduganathan, Carolyn S Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Meike Brinker, Flaviana Amarante, Katja Rohwedder, James Lay-Flurrie, Scott D Solomon, John JV McMurray, Pardeep S Jhund



Fast Approximation of Joint Models: A Comparative Evaluation of Bayesian Methods

Jinghao Li, David M Hughes



Confidence Intervals for Comparing Two Independent Folded Normals

Eleonora Di Carluccio, Sarah Ogutu, Ozkan Köse, Henry G. Mwambi, Andreas Ziegler



Towards Realistic Synthetic Nanopore Protein Signals: A Comparative Study of Stochastic and GAN-Based Methods

Göran Köber, Jonas Bürgel, Tobias Ensslen, Oliver Amft



Data Transformations in Machine Learning Approaches for Studying Microbiota as a Biomarker of Non-Response Risk to CFTR Modulators

Marta Avalos, Céline Hosteins, Diego Kauer, Chloé Renault, Raphaël Enaud, Laurence Delhaes



On microbiome data analysis using Bayesian method under the assumption of a zero-inflated model

Yuki Ando, Asanao Shimokawa



Estimating prevalence of cystic fibrosis heterozygosity using Fast Boltzmann Inversion (FBI): An improved Monte Carlo algorithm for Bayesian inference

Jan Brink Valentin



A Sparse Graph Representation of Hi-C Data for Colorectal Cancer Prediction

Jiwon Im, Mingyu Go, Insu Jang, Minsu Park



A multi-state survival model for recurring adenomas in Lynch syndrome individuals

Vanessa García López-Mingo, Veerle Coupé, Marjolein Greuter, Thomas Klausch



Evaluating Completeness of Data in CPRD’s Breast Cancer Data: Implications for External Controls for Surrogate Endpoints

Dorcas N Kareithi, Jingky Lozano-Kuehne, David Sinclair, James Wason



Identification of risk factors for the development of de novo malignancies after liver transplantation

Tereza Hakova, Pavel Taimr, Tomáš Hucl, Zdeněk Valenta



Are ACE inhibitors associated with increased lung cancer risk, or are unmeasured confounders biasing results?

Sean Maguire, Ruth Keogh, Elizabeth Williamson, John Tazare



DO GENETIC CHANGES IN 15Q13.3 MEAN LOWER IQ SCORE?

Tadas Žvirblis, Pilar Caro, Audronė Jakaitienė, Christian Schaaf



Measuring the performance of survival models to personalize treatment choices

Orestis Efthimiou, Jeroen Hoogland, Thomas Debray, Valerie Aponte Ribero, Wilma Knol, Huiberdina Koek, Matthias Schwenkglenks, Séverine Henrard, Matthias Egger, Nicolas Rodondi, Ian White



A framework for estimating quality adjusted life years using joint models of longitudinal and survival data

Michael Crowther, Alessandro Gasparini, Sara Ekberg, Federico Felizzi, Elaine Gallagher, Noman Paracha



Cut Off Determination using Model Derived Estimate in Survival Prediction Model

Jungbok Lee



A two-step testing approach for comparing time-to-event data under non-proportional hazards

Jonas Brugger, Tim Friede, Florian Klinglmüller, Martin Posch, Franz König



A systematic review of Bayesian survival modelling for extrapolating survival in cost-effectiveness analysis

Farah Erdogan, Gwénaël Le Teuff



Power comparison of hazard ratio versus restricted mean survival time in the presence of cure

Ronald Bertus Geskus



Sample Size Calculation in Prognostic Studies: A Comparative Analysis

Gloria Brigiari, Ester Rosa, Giulia Lorenzoni, Dario Gregori



Prognostic Score Adjustment in a Two-Slope Mixed Effects Model to Estimate Treatment Effects on eGFR Slope in CKD Patients

Silke Janitza, Maike Ahrens, Sebastian Voss, Bohdana Ratitch, Nicole Rethemeier, Meike Brinker, Paula Vesterinen, Antigoni Elefsinioti



Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers to prevent or delay dementia: a target trial emulation

Marie-Laure Charpignon, Max Sunog, Colin Magdamo, Bella Vakulenko-Lagun, Ioanna Tzoulaki, Sudeshna Das, Deborah Blacker, Mark Albers



Optimal utility-based design of phase II/phase III programmes with different type of endpoints in the setting of multiple myeloma

Haotian Wang, Peter Kimani, Michael Grayling, Josephine Khan, Nigel Stallard



Beyond first events: Advancing recurrent adverse event estimates in clinical research.

Nicolas Sauvageot, Leen Slaets, Anirban Mitra, Zoe Craig, Jane Gilbert, Lilla Di Scala, Stefan Englert



Cure models to compare aftercare monitoring schemes in pediatric cancer

Ulrike Pötschger, Harm van Tinteren, Evgenia Glogova, Helga Arnardottir, Paulina Kurzmann, Sabine Taschner-Mandl, Lieve Titgat, Martina Mittlböck



Comparison of treatment sequences in advanced pancreatic cancer

Norbert Marschner, Nina Haug, Susanna Hegewisch-Becker, Marcel Reiser, Steffen Dörfel, Rüdiger Liersch, Hartmut Linde, Thomas Wolf, Anna Hof, Anja Kaiser-Osterhues, Karin Potthoff, Martina Jänicke



Clinical Trials with Time-to-event-endpoint: Interim Prediction of Number of Events with Confidence Distributions

Edoardo Ratti, Maria Grazia Valsecchi, Stefania Galimberti



A Bayesian-Informed Dose-Escalation Design for Multi-Cohort Oncology Trials with Varying Maximum Tolerated Doses

Martin Kappler, Yuan Ji



Comparison of Bayesian Approaches in Single-Agent Dose-Finding Studies

Vibha Srichand



Evaluating the effect of different non-informative prior specifications on the Bayesian proportional odds model in randomised controlled trials

Chris J Selman, Katherine J Lee, Michael Dymock, Ian Marschner, Steven Y.C. Tong, Mark Jones, Tom Snelling, Robert K Mahar



Bayesian decision analysis for clinical trial design with binary outcome in the context of Ebola Virus Disease outbreak – Simulation study

Drifa Belhadi, Joonhyuk Cho, Pauline Manchon, Denis Malvy, France Mentré, Andrew W Lo, Cédric Laouénan



Relevance of Electronic Medical Records for Clinical Trial Eligibility: A Feasibility Assessment in Acute Stroke Studies

Yusuke Sasahara, Taizo Murata, Yasufumi Gon, Toshihiro Takeda, Eisuke Hida



Navigating complex and computationally demanding clinical trial simulation

Saumil Shah, Mitchell Thomann



Transforming Clinical Trials: The Power of Synthetic Data in Augmenting Control Arms

Emmanuelle Boutmy, Shane O Meachair, Julie Zhang, Sabrina de Souza, Saheli Das, Dina Oksen, Anna Tafuri, Lucy Mosquera



Integrating stakeholder perspectives in modeling routine data for therapeutic decision-making

Michelle Pfaffenlehner, Andrea Dreßing, Dietrich Knoerzer, Markus Wagner, Peter Heuschmann, André Scherag, Harald Binder, Nadine Binder



Aligning Synthetic Trajectories from Expert-Based Models with Real Patient Data Using Low-Dimensional Representations

Hanning Yang, Meropi Karakioulaki, Cristina Has, Moritz Hess, Harald Binder



Integrating semantic information in care pathway studies with medical code embeddings, application to the case of Amyotrophic Lateral Sclerosis

Corentin FAUJOUR, Stéphane BOUEE, Corinne EMERY, Anne-Sophie JANNOT



Inequalities in impact of respiratory viruses: development and analysis of respiratory virus phenotypes in EHRs from England using OpenSAFELY

Em Prestige, Jennifer K. Quint, Charlotte Warren-Gash, William Hulme, Edward PK Parker, Elizabeth Williamson, Rosalind M. Eggo



Modeling Longitudinal Clinical Outcomes: Comparison of Generalized Linear Models, Generalized Estimating Equations, and Marginalized Multilevel Models in Pediatric Intensive Care

Luca Vedovelli, Stefania Lando, Danila Azzolina, Corrado Lanera, Ileana Baldi, Dario Gregori



Modelling the costeffectiveness of Truvada for the Prevention of Mother to Child Prevention (PMTCT) of Hepatitis B Virus in Botswana

Graceful Mulenga, Motswedi Anderson, Simani Gaseitsiwe



Application of machine learning methods for the analysis of randomised controlled trials: A systematic review

Xiao Xuan Tan, Rachel Phillips, Mansour Taghavi Azar Sharabiani



Joint longitudinal modelling of non-normally distributed outcomes and endogenous covariates

Chiara Degan, Bart Mertens, Pietro Spitali, Erik H. Niks, Jelle Goeman, Roula Tsonaka



Mediation analysis for exploring gender differences in mortality among acute myocardial infarction

Alice Bonomi, Arianna Galotta, Francesco Maria Mattio, Lorenzo Cangiano, Giancarlo Marenzi



Bivariate random-effects models for the meta-analysis of rare events

Danyu Li, Patrick Taffe



Time-varying Decomposition of Direct and Indirect Effects with Multiple Longitudinal Mediators

Yasuyuki Okuda, Masataka Taguri



Causal framework for analyzing mediation effects of clinical biomarkers

Jinesh Shah



A Modified Doubly Robust Estimator for Clustered Causal Inference: Integrating GLMM and GBM

Samina Naznin, Dr. Mohaimen Monsur



DoubleMLDeep: Estimation of Causal Effects with Multimodal Data

Martin Spindler, Victor Chernozhukov, Philipp Bach, Jan Teichert-Kluge, Sven Klaassen, Suhas Vijaykumar



Causal Machine Learning Methods for Estimating Personalised Treatment Effects - Insights on validity from two large trials

Hongruyu Chen, Helena Aebersold, Milo Alan Puhan, Miquel Serra-Burriel



Challenges with subgroup analyses in individual participant data meta-analysis of randomised trials

Alain Amstutz, Dominique Costagliola, Corina S. Rueegg, Erica Ponzi, Johannes M. Schwenke, France Mentré, Clément R. Massonnaud, Cédric Laouénan, Aliou Baldé, Lambert Assoumou, Inge C. Olsen, Matthias Briel, Stefan Schandelmaier



Illustration and evaluation of a causal approach to sensitivity analysis for unmeasured confounding using measured proxies with a simulation study

Nerissa Nance, Romain Neugebauer



Quantifying causal treatment effect on binary outcome in RCTs with noncompliance: estimating risk difference, risk ratio and odds ratio

Junxian Zhu, Mark Y. Chan, Bee-Choo Tai



Blinded sample size recalculation for randomized controlled trials with analysis of covariance

Takumi Kanata, Yasuhiro Hagiwara, Koji Oba



Variance stabilization transformation for the intraclass correlation coefficient of agreement with an application example to meta-analyses of inter-rater reliability studies

Abderrahmane Bourredjem, Isabelle Fournel, Sophie Vanbelle, Nadjia El Saadi



Bridging Single Arm Studies with Individual Participant Data in Network Meta-Analysis of Randomized Controlled Trials: A Simulation Study

Katerina Maria Kontouli, Stavros Nikolakopoulos, Christos Christogiannis, Dimitrios Mavridis



Comparative Efficacy and Safety of Migraine Treatments: A Network Meta-Analysis of Clinical Outcomes

Shashank Tripathi, Rachna Agarwal



Optimal standardization as an alternative to matching using propensity scores

Ekkehard Glimm, Lillian Yau



Evaluating Diagnostic Tests Against Composite Reference Standards: Quantifying and Adjusting for Bias

Vera Hudak, Nicky J. Welton, Efthymia Derezea, Hayley Jones



Characteristics, Design and Statistical Methods in Platform Trials: A Systematic Review

Clément R. Massonnaud, Christof Manuel Schönenberger, Malena Chiaborelli, Selina Ehrenzeller, Alexandra Griessbach, André Gillibert, Matthias Briel, Cédric Laouénan



WRestimates: An R Package for Win-Ratio Sample Size and Power Calculations

Autumn O Donnell



Randomizing With Investigator Choice of Treatment: A Powerful Pragmatic Tool in Clinical Trials

Lillian Yau, Betty Molloy



Confirming assay sensitivity in 2-arm non-inferiority trial using meta-analytic-predictive approach

Satomi OKAMURA, Eisuke HIDA



Adding baskets to an ongoing basket trial with information borrowing: When do you benefit?

Libby Daniells, Pavel Mozgunov, Helen Barnett, Alun Bedding, Thomas Jaki



Optimizing Adaptive Trial Design to Ensure Robustness Across Varying Treatment Effect Assumptions

Valeria Mazzanti, Dirk Klingbiel



N-of-1 Trials to Estimate Individual Effects of Music on Concentration

Thomas Gärtner, Fabian Stolp, Stefan Konigorski



Simulation Study Examining Impact of Study Design Factors on Variability Measures

Laura Quinn, Jon Deeks, Yemisi Takwoingi, Alice Sitch



Simulation-based optimization of adaptive designs using a generalized version of assurance

Pantelis Vlachos, Valeria Mazzanti, Boaz Adler



Evaluating the impact of outcome delay on adaptive designs

Aritra Mukherjee, Michael J. Grayling, James M. S. Wason

4:00pm
-
5:30pm
Generative AI in clinical research and drug development (BBS invited session)
Location: Biozentrum U1.111
 

Generative Scientific Machine Learning for Advancement of Pharmacokinetic Modeling

Holger Fröhlich



(Generative) AI in medicine: Where does statistics come into play?

Sarah Friedrich



Do Single-Cell Transformers Understand Gene Regulation? A Cautionary Benchmark

Simon Anders, Constantin Ahlmann-Eltze, Wolfgang Huber

Efficient use of interim analyses in clinical trials
Location: Biozentrum U1.131
 

Innovative clinical trial approach for evaluating digital medical devices under European fast-track regulatory frameworks

Moreno Ursino, Sandrine Boulet, Raphaël Porcher, Edouard Lhomme, Florence Francis-Oliviero, Gaël Varoquaux, Florence Saillour, Corinne Collignon, Rodolphe Thiébaut, Sarah Zohar



Using only an early outcome for interim decisions regarding treatment effect on a long-term endpoint: a practical implementation

Tomasz Burzykowski, Leandro Garcia Barrado



Calibrated Risk-Scale: A Proposed Futility Design Framework to Enhance Portfolio-Level Profitability and Performance

Nima Shariati



Interim analysis under treatment effect heterogeneity

Audrey Boruvka



When to Schedule the Interim Analysis in the Presence of Missing Data?

Neža Dvoršak, Jianmei Wang, Thomas Burnett, Christopher Jennison, Robin Mitra

Survival analysis 3
Location: Biozentrum U1.141
 

Estimating the new event-free survival

Judith Vilsmeier, Maral Saadati, Kaya Miah, Axel Benner, Hartmut Döhner, Jan Beyersmann



Marginal Matched Pairs Cox Regression

Jana Kinzel, Jan Beyersmann



Using Restricted Mean Survival Time under proportional hazards in a non-inferiority randomised trial with time-to-event outcome

Matteo Quartagno, Matt Nankivell, Tim Morris, Ian White



Variable selection methodology for illness-death model with interval censored data

Ariane BERCU, Agathe GUILLOUX, Cécile PROUST-LIMA, Hélène JACQMIN-GADDA



Modelling the time-varying effect of hormonal treatment on metastasis-free survival among ER+ breast cancer patients - a natural history modelling approach

Letizia Orsini, Alessandro Gasparini, Kamila Czene, Keith Humphreys

Causal inference in time-varying settings
Location: Biozentrum U1.101
 

The causal effect of gold standard midwifery staffing on the occurrence of spontaneous vaginal births – A target trial emulation

Luisa Eggenschwiler, Valerie Smith, Michael Simon, Giusi Moffa



A new encoding of time-varying treatment regimes for the study of sequential per-protocol effects

Ignacio Gonzalez-Perez, Mats Julius Stensrud



Optimal sequential decision-making with initiation regimes

Julien David Laurendeau, Aaron Leor Sarvet, Mats Julius Stensrud



Evaluating the effect of lung transplantation: a case study in sequential emulated trials with time varying confounding

Iqraa Meah, Fançois Petit, Raphaël Porcher



Unraveling time-varying causal effects of multiple exposures: a novel approach integrating Functional Data analysis into the multivariable Mendelian Randomization framework

Nicole Fontana, Piercesare Secchi, Emanuele Di Angelantonio, Francesca Ieva

Prediction / prognostic modelling 4
Location: ETH E27
 

Adapting existing sample size calculations for developing risk prediction models to control for model stability

Gareth Ambler, Menelaos Pavlou, Rumana Z Omar



Optimal Methods for Handling Continuous Predictors in Clinical Prediction Model Development: Balancing Flexibility and Stability

Phichayut Phinyo, Pakpoom Wongyikul, Noraworn Jirattikanwong, Natthanaphop Isaradech, Wachiranun Sirikul, Wuttipat Kiratipaisarl, Noppadon Seesuwan, Suppachai Lawanaskol



Do Stable Performance Metrics Guarantee Stable Model Predictions?

Natthanaphop Isaradech, Phichayut Phinyo, Wuttipat Kiratipaisarl, Pakpoom Wongyikul, Noraworn Jirattikanwong, Wachiranun Sirikul



The Imbalance Dilemma: Can Class Imbalance Corrections Stabilize Clinical Prediction Models?

Wachiranun Sirikul, Natthanaphop Isaradech, Wuttipat Kiratipaisarl, Phichayut Phinyo, Pakpoom Wongyeekul, Noraworn Jirattikanwong



Prediction with Logistic Regression in Binary Class Imbalance: comparing re-sampling techniques with threshold probability assignment under varying predictive covariates

Henk van der Pol, Ragnhild Sørum Falk, Marta Fiocco, Arnoldo Frigessi, Euloge Clovis Kenne Pagui

Meta-analysis 3
Location: ETH E23
 

Meta-Analysis of Time-to-Event Outcomes with Non-Proportional Hazards - A Time-Varying Hazard Ratio Approach

Keith R Abrams, Rhiannon K Owen



Flexing the Curve: Comparing Spline and Fractional Polynomial Models in Network Meta-Analysis of Survival Outcomes

Suraj Balakrishna, Justin Chumbley, Natalia Popova, Shahrul Mt-Isa



Fixed and random effect meta-analysis for competing risks: a how-to guide for aggregated and individual participant data

Matthias Klimek, Matthias Schmid, Anja Rüten-Budde, Andreas Ziegler



The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: a network meta-analysis.

Jordache Ramjith, Leen N. Vanheer, Almahamoudou Mahamar, Merel J. Smit, Kjerstin Lanke, Michelle E. Roh, Koualy Sanogo, Youssouf Sinaba, Sidi M. Niambele, Makonon Diallo, Seydina O. Maguiraga, Sekouba Keita, Siaka Samake, Ahamadou Youssouf, Halimatou Diawara, Sekou F. Traore, Roly Gosling, Joelle M. Brown, Chris Drakeley, Alassane Dicko, Will Stone, Teun Bousema



Meta-analysis of diagnostic test accuracy with multiple disease states: combining stage-specific accuracy data with descriptive statistics

Efthymia Derezea, Gabriel Rogers, Nicky Welton, Hayley E Jones

Observational/real-world data 2
Location: ETH E21
 

Group measurement invariance assessment with item-level latent variable models: A comparative simulation study of two methods

Myriam Blanchin, Odile Stahl, Yseulys Dubuy, Véronique Sébille



Linkage of HIV treatment and population-based surveillance records in rural South Africa

Dickman Gareta, Evelyn Lauren, Khumbo Shumba, Cornelius Nattey, William Macleod, Matthew P. Fox, Koleka Mlisana, Matthias Egger, Dorina Onoya, Kobus Herbst, Jacob Bor



Investigating Statistical Inference for Consistency, Heterogeneity and Efficacy of Federated Learning Models: Insights from a Mega-Simulation of Real-World Data

Narayan Sharma, Gonzalo Durán-Pacheco, Jacek Chmiel, Eric Boernert, Doug Kelkhoff, Vittorio P. Illiano, Gabriele Zilorri, Matthias Antonin, Bjoern Tackenberg, Dominik Heinzmann



Characterizing Medication Timelines in Huntington’s Disease: A Cluster-Based Analysis of Treatment Patterns

Marc Dibling, Alexandra Durr, Sophie Tezenas du Montcel



Testing the Similarity of Healthcare Pathways based on Transition Probabilities - A New Bootstrap Procedure

Zoe Lange, Holger Dette, Maryam Farhadizadeh, Nadine Binder

Poster Exhibition: W / Wednesday posters
Location: Poster Location
 

Exploring the Exposome correlated with Body Mass Index in Adolescents: Findings from the 2014-2015 and 2022-2023 KNHANES

Hye Ah Lee, Hyesook Park



Flexible statistical modeling of undernutrition among under-five children in India

SHAMBHAVI MISHRA



Comparison of deep learning models with different architectures and training populations for ECG age estimation: Accuracy, agreement, and CVD prediction

Arya Panthalanickal Vijayakumar, Tom Wilsgaard, Henrik Schirmer, Ernest Diez Benavente, René van Es, Rutger R. van de Leur, Haakon Lindekleiv, Zachi I. Attia, Francisco Lopez-Jimenez, David A. Leon, Olena Iakunchykova



Systematic review and real life-oriented evaluation on methods for feature selection in longitudinal biomedical data

Alexander Gieswinkel, Gregor Buch, Gökhan Gül, Vincent ten Cate, Lisa Hartung, Philipp S. Wild



How does acute exposure to environmental factors relate to stroke characteristics such as stroke type, severity, and impairments?

BOHAN ZHANG, Andy Vail, Craig Smith, Amit Kishore, Matthew Gittins



Improving TBI Prognosis in developing world: A Machine Learning-based AutoScore Approach to Predict Six-Month Functional Outcome

Vineet Kumar Kamal, Deepak Agrawal



Predictive Risk Index for Poor Cognitive Development Among Children Using Machine Learning Approaches

Anita Kerubo Ogero, Patricia Kipkemoi, Amina Abubakar



Development and validation of a model to predict ceiling of care in COVID-19 hospitalised patients

Natàlia Pallarès Fontanet, Hristo Inouzhe, Jordi Cortés, Sam Straw, Klaus K Witte, Jordi Carratalà, Sebastià Videla, Cristian Tebé



Transformer Models for Clinical Prediction – Investigation of BEHRT in UK Biobank and prediction assessment under different scenarios

Yusuf Yildiz, Goran Nenadic, Meghna Jani, David A. Jenkins



What is the best way to analyse ventilator-free days?

Laurent Renard Triché, Matthieu Jabaudon, Bruno Pereira, Sylvie Chevret



Compare Estimation and Classification Performances of Statistical Shrinkage Methods Ridge Regression, Lasso Regression, and Elastic Net Regression

Gamze Ozen, Fezan Mutlu



Defining Harm in Settings with Outcomes that are Not Binary

Amit Sawant, Mats Stensrud



Brier pseudo-observation score for selecting a multiplicative, an additive or an additive-multiplicative hazards regression model

François Lefebvre, Roch Giorgi



Bayesian spatio-temporal analysis of the COVID-19 pandemic in Catalonia

Pau Satorra, Cristian Tebé



A Simulation Study of Bayesian Approaches to Spatial Modelling Using the Besag-York-Mollie Model

Hollie Hughes, David Hughes



A Bayesian analysis of FINEARTS-HF

Alasdair D Henderson, Brian L Claggett, Akshay S Desai, Mutthiah Vaduganathan, Carolyn S Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Meike Brinker, Flaviana Amarante, Katja Rohwedder, James Lay-Flurrie, Scott D Solomon, John JV McMurray, Pardeep S Jhund



Fast Approximation of Joint Models: A Comparative Evaluation of Bayesian Methods

Jinghao Li, David M Hughes



Confidence Intervals for Comparing Two Independent Folded Normals

Eleonora Di Carluccio, Sarah Ogutu, Ozkan Köse, Henry G. Mwambi, Andreas Ziegler



Towards Realistic Synthetic Nanopore Protein Signals: A Comparative Study of Stochastic and GAN-Based Methods

Göran Köber, Jonas Bürgel, Tobias Ensslen, Oliver Amft



Data Transformations in Machine Learning Approaches for Studying Microbiota as a Biomarker of Non-Response Risk to CFTR Modulators

Marta Avalos, Céline Hosteins, Diego Kauer, Chloé Renault, Raphaël Enaud, Laurence Delhaes



On microbiome data analysis using Bayesian method under the assumption of a zero-inflated model

Yuki Ando, Asanao Shimokawa



Estimating prevalence of cystic fibrosis heterozygosity using Fast Boltzmann Inversion (FBI): An improved Monte Carlo algorithm for Bayesian inference

Jan Brink Valentin



A Sparse Graph Representation of Hi-C Data for Colorectal Cancer Prediction

Jiwon Im, Mingyu Go, Insu Jang, Minsu Park



A multi-state survival model for recurring adenomas in Lynch syndrome individuals

Vanessa García López-Mingo, Veerle Coupé, Marjolein Greuter, Thomas Klausch



Evaluating Completeness of Data in CPRD’s Breast Cancer Data: Implications for External Controls for Surrogate Endpoints

Dorcas N Kareithi, Jingky Lozano-Kuehne, David Sinclair, James Wason



Identification of risk factors for the development of de novo malignancies after liver transplantation

Tereza Hakova, Pavel Taimr, Tomáš Hucl, Zdeněk Valenta



Are ACE inhibitors associated with increased lung cancer risk, or are unmeasured confounders biasing results?

Sean Maguire, Ruth Keogh, Elizabeth Williamson, John Tazare



DO GENETIC CHANGES IN 15Q13.3 MEAN LOWER IQ SCORE?

Tadas Žvirblis, Pilar Caro, Audronė Jakaitienė, Christian Schaaf



Measuring the performance of survival models to personalize treatment choices

Orestis Efthimiou, Jeroen Hoogland, Thomas Debray, Valerie Aponte Ribero, Wilma Knol, Huiberdina Koek, Matthias Schwenkglenks, Séverine Henrard, Matthias Egger, Nicolas Rodondi, Ian White



A framework for estimating quality adjusted life years using joint models of longitudinal and survival data

Michael Crowther, Alessandro Gasparini, Sara Ekberg, Federico Felizzi, Elaine Gallagher, Noman Paracha



Cut Off Determination using Model Derived Estimate in Survival Prediction Model

Jungbok Lee



A two-step testing approach for comparing time-to-event data under non-proportional hazards

Jonas Brugger, Tim Friede, Florian Klinglmüller, Martin Posch, Franz König



A systematic review of Bayesian survival modelling for extrapolating survival in cost-effectiveness analysis

Farah Erdogan, Gwénaël Le Teuff



Power comparison of hazard ratio versus restricted mean survival time in the presence of cure

Ronald Bertus Geskus



Sample Size Calculation in Prognostic Studies: A Comparative Analysis

Gloria Brigiari, Ester Rosa, Giulia Lorenzoni, Dario Gregori



Prognostic Score Adjustment in a Two-Slope Mixed Effects Model to Estimate Treatment Effects on eGFR Slope in CKD Patients

Silke Janitza, Maike Ahrens, Sebastian Voss, Bohdana Ratitch, Nicole Rethemeier, Meike Brinker, Paula Vesterinen, Antigoni Elefsinioti



Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers to prevent or delay dementia: a target trial emulation

Marie-Laure Charpignon, Max Sunog, Colin Magdamo, Bella Vakulenko-Lagun, Ioanna Tzoulaki, Sudeshna Das, Deborah Blacker, Mark Albers



Optimal utility-based design of phase II/phase III programmes with different type of endpoints in the setting of multiple myeloma

Haotian Wang, Peter Kimani, Michael Grayling, Josephine Khan, Nigel Stallard



Beyond first events: Advancing recurrent adverse event estimates in clinical research.

Nicolas Sauvageot, Leen Slaets, Anirban Mitra, Zoe Craig, Jane Gilbert, Lilla Di Scala, Stefan Englert



Cure models to compare aftercare monitoring schemes in pediatric cancer

Ulrike Pötschger, Harm van Tinteren, Evgenia Glogova, Helga Arnardottir, Paulina Kurzmann, Sabine Taschner-Mandl, Lieve Titgat, Martina Mittlböck



Comparison of treatment sequences in advanced pancreatic cancer

Norbert Marschner, Nina Haug, Susanna Hegewisch-Becker, Marcel Reiser, Steffen Dörfel, Rüdiger Liersch, Hartmut Linde, Thomas Wolf, Anna Hof, Anja Kaiser-Osterhues, Karin Potthoff, Martina Jänicke



Clinical Trials with Time-to-event-endpoint: Interim Prediction of Number of Events with Confidence Distributions

Edoardo Ratti, Maria Grazia Valsecchi, Stefania Galimberti



A Bayesian-Informed Dose-Escalation Design for Multi-Cohort Oncology Trials with Varying Maximum Tolerated Doses

Martin Kappler, Yuan Ji



Comparison of Bayesian Approaches in Single-Agent Dose-Finding Studies

Vibha Srichand



Evaluating the effect of different non-informative prior specifications on the Bayesian proportional odds model in randomised controlled trials

Chris J Selman, Katherine J Lee, Michael Dymock, Ian Marschner, Steven Y.C. Tong, Mark Jones, Tom Snelling, Robert K Mahar



Bayesian decision analysis for clinical trial design with binary outcome in the context of Ebola Virus Disease outbreak – Simulation study

Drifa Belhadi, Joonhyuk Cho, Pauline Manchon, Denis Malvy, France Mentré, Andrew W Lo, Cédric Laouénan



Relevance of Electronic Medical Records for Clinical Trial Eligibility: A Feasibility Assessment in Acute Stroke Studies

Yusuke Sasahara, Taizo Murata, Yasufumi Gon, Toshihiro Takeda, Eisuke Hida



Navigating complex and computationally demanding clinical trial simulation

Saumil Shah, Mitchell Thomann



Transforming Clinical Trials: The Power of Synthetic Data in Augmenting Control Arms

Emmanuelle Boutmy, Shane O Meachair, Julie Zhang, Sabrina de Souza, Saheli Das, Dina Oksen, Anna Tafuri, Lucy Mosquera



Integrating stakeholder perspectives in modeling routine data for therapeutic decision-making

Michelle Pfaffenlehner, Andrea Dreßing, Dietrich Knoerzer, Markus Wagner, Peter Heuschmann, André Scherag, Harald Binder, Nadine Binder



Aligning Synthetic Trajectories from Expert-Based Models with Real Patient Data Using Low-Dimensional Representations

Hanning Yang, Meropi Karakioulaki, Cristina Has, Moritz Hess, Harald Binder



Integrating semantic information in care pathway studies with medical code embeddings, application to the case of Amyotrophic Lateral Sclerosis

Corentin FAUJOUR, Stéphane BOUEE, Corinne EMERY, Anne-Sophie JANNOT



Inequalities in impact of respiratory viruses: development and analysis of respiratory virus phenotypes in EHRs from England using OpenSAFELY

Em Prestige, Jennifer K. Quint, Charlotte Warren-Gash, William Hulme, Edward PK Parker, Elizabeth Williamson, Rosalind M. Eggo



Modeling Longitudinal Clinical Outcomes: Comparison of Generalized Linear Models, Generalized Estimating Equations, and Marginalized Multilevel Models in Pediatric Intensive Care

Luca Vedovelli, Stefania Lando, Danila Azzolina, Corrado Lanera, Ileana Baldi, Dario Gregori



Modelling the costeffectiveness of Truvada for the Prevention of Mother to Child Prevention (PMTCT) of Hepatitis B Virus in Botswana

Graceful Mulenga, Motswedi Anderson, Simani Gaseitsiwe



Application of machine learning methods for the analysis of randomised controlled trials: A systematic review

Xiao Xuan Tan, Rachel Phillips, Mansour Taghavi Azar Sharabiani



Joint longitudinal modelling of non-normally distributed outcomes and endogenous covariates

Chiara Degan, Bart Mertens, Pietro Spitali, Erik H. Niks, Jelle Goeman, Roula Tsonaka



Mediation analysis for exploring gender differences in mortality among acute myocardial infarction

Alice Bonomi, Arianna Galotta, Francesco Maria Mattio, Lorenzo Cangiano, Giancarlo Marenzi



Bivariate random-effects models for the meta-analysis of rare events

Danyu Li, Patrick Taffe



Time-varying Decomposition of Direct and Indirect Effects with Multiple Longitudinal Mediators

Yasuyuki Okuda, Masataka Taguri



Causal framework for analyzing mediation effects of clinical biomarkers

Jinesh Shah



A Modified Doubly Robust Estimator for Clustered Causal Inference: Integrating GLMM and GBM

Samina Naznin, Dr. Mohaimen Monsur



DoubleMLDeep: Estimation of Causal Effects with Multimodal Data

Martin Spindler, Victor Chernozhukov, Philipp Bach, Jan Teichert-Kluge, Sven Klaassen, Suhas Vijaykumar



Causal Machine Learning Methods for Estimating Personalised Treatment Effects - Insights on validity from two large trials

Hongruyu Chen, Helena Aebersold, Milo Alan Puhan, Miquel Serra-Burriel



Challenges with subgroup analyses in individual participant data meta-analysis of randomised trials

Alain Amstutz, Dominique Costagliola, Corina S. Rueegg, Erica Ponzi, Johannes M. Schwenke, France Mentré, Clément R. Massonnaud, Cédric Laouénan, Aliou Baldé, Lambert Assoumou, Inge C. Olsen, Matthias Briel, Stefan Schandelmaier



Illustration and evaluation of a causal approach to sensitivity analysis for unmeasured confounding using measured proxies with a simulation study

Nerissa Nance, Romain Neugebauer



Quantifying causal treatment effect on binary outcome in RCTs with noncompliance: estimating risk difference, risk ratio and odds ratio

Junxian Zhu, Mark Y. Chan, Bee-Choo Tai



Blinded sample size recalculation for randomized controlled trials with analysis of covariance

Takumi Kanata, Yasuhiro Hagiwara, Koji Oba



Variance stabilization transformation for the intraclass correlation coefficient of agreement with an application example to meta-analyses of inter-rater reliability studies

Abderrahmane Bourredjem, Isabelle Fournel, Sophie Vanbelle, Nadjia El Saadi



Bridging Single Arm Studies with Individual Participant Data in Network Meta-Analysis of Randomized Controlled Trials: A Simulation Study

Katerina Maria Kontouli, Stavros Nikolakopoulos, Christos Christogiannis, Dimitrios Mavridis



Comparative Efficacy and Safety of Migraine Treatments: A Network Meta-Analysis of Clinical Outcomes

Shashank Tripathi, Rachna Agarwal



Optimal standardization as an alternative to matching using propensity scores

Ekkehard Glimm, Lillian Yau



Evaluating Diagnostic Tests Against Composite Reference Standards: Quantifying and Adjusting for Bias

Vera Hudak, Nicky J. Welton, Efthymia Derezea, Hayley Jones



Characteristics, Design and Statistical Methods in Platform Trials: A Systematic Review

Clément R. Massonnaud, Christof Manuel Schönenberger, Malena Chiaborelli, Selina Ehrenzeller, Alexandra Griessbach, André Gillibert, Matthias Briel, Cédric Laouénan



WRestimates: An R Package for Win-Ratio Sample Size and Power Calculations

Autumn O Donnell



Randomizing With Investigator Choice of Treatment: A Powerful Pragmatic Tool in Clinical Trials

Lillian Yau, Betty Molloy



Confirming assay sensitivity in 2-arm non-inferiority trial using meta-analytic-predictive approach

Satomi OKAMURA, Eisuke HIDA



Adding baskets to an ongoing basket trial with information borrowing: When do you benefit?

Libby Daniells, Pavel Mozgunov, Helen Barnett, Alun Bedding, Thomas Jaki



Optimizing Adaptive Trial Design to Ensure Robustness Across Varying Treatment Effect Assumptions

Valeria Mazzanti, Dirk Klingbiel



N-of-1 Trials to Estimate Individual Effects of Music on Concentration

Thomas Gärtner, Fabian Stolp, Stefan Konigorski



Simulation Study Examining Impact of Study Design Factors on Variability Measures

Laura Quinn, Jon Deeks, Yemisi Takwoingi, Alice Sitch



Simulation-based optimization of adaptive designs using a generalized version of assurance

Pantelis Vlachos, Valeria Mazzanti, Boaz Adler



Evaluating the impact of outcome delay on adaptive designs

Aritra Mukherjee, Michael J. Grayling, James M. S. Wason

6:00pm
-
11:00pm
Conference Dinner

 
Contact and Legal Notice · Contact Address:
Privacy Statement · Conference: ISCB46
Conference Software: ConfTool Pro 2.6.154+TC
© 2001–2025 by Dr. H. Weinreich, Hamburg, Germany